Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,21282,44,2.08 [0.42-10.19],0.3678506428335034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,20668,42,0.89 [0.51-1.55],0.6696882495259239
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,24385,49,1.29 [0.84-1.98],0.2430805748121595
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,20594,43,1.08 [0.49-2.39],0.8448259793815285
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,24261,49,0.89 [0.58-1.38],0.6081600149169264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,24385,49,0.99 [0.69-1.43],0.9692784869250496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,21262,44,1.03 [0.85-1.26],0.7627590335740732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,20594,43,0.84 [0.53-1.32],0.4479120362230665
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",23920,49,0.89 [0.65-1.22],0.469545791526083
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",20858,44,0.40 [0.20-0.80],0.0099819390446238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",21257,44,1.03 [0.75-1.42],0.8497766568839346
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,24287,48,5.67 [2.45-13.13],4.996187106310266e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,21262,44,1.07 [0.34-3.31],0.9124241602509894
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,24072,47,0.84 [0.50-1.40],0.4926618748251391
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,20778,43,0.93 [0.40-2.19],0.8703220478030393
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,21165,44,0.93 [0.73-1.20],0.5874843008787204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,24515,49,0.81 [0.48-1.39],0.4467038691258138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,20648,42,0.86 [0.43-1.69],0.6526749994871957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,24585,48,1.36 [0.66-2.81],0.408559809347557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,24690,48,2.23 [1.43-3.49],0.0003883315492722
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,21141,44,0.53 [0.23-1.21],0.1312859796243043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,20648,42,0.80 [0.57-1.12],0.188923573906621
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,20594,43,0.81 [0.33-1.99],0.639589947026243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",24072,47,1.89 [1.34-2.68],0.0003320388876589
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,20594,43,1.23 [0.81-1.88],0.3384147139004745
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,24057,47,1.32 [0.67-2.62],0.4203652025427346
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,24307,49,2.58 [1.00-6.69],0.0506649114941335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,24515,49,0.97 [0.66-1.42],0.867234262365072
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,20594,43,1.21 [0.75-1.96],0.425367456192028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,20699,43,0.97 [0.62-1.50],0.8802034498374429
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,24802,48,1.21 [0.62-2.37],0.5762158754985165
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,24325,48,2.08 [1.19-3.65],0.0101641103641259
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,20648,42,1.50 [0.93-2.43],0.0946582645522573
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,24072,47,2.66 [1.18-6.00],0.0180951747540444
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,24348,49,2.04 [1.00-4.14],0.0489526457615742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,24802,48,2.54 [1.13-5.74],0.024636477949659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,24701,49,1.10 [0.45-2.66],0.8350278888654009
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,21165,44,3.33 [1.81-6.13],0.0001081384296536
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,20648,42,1.05 [0.43-2.61],0.908735896730858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,24797,49,0.57 [0.20-1.63],0.2920868353748941
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,24385,49,2.09 [1.14-3.83],0.0174989680865341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,24072,47,0.98 [0.44-2.17],0.955736491537992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,20648,42,1.30 [0.61-2.75],0.4933218110784779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,24550,47,1.06 [0.60-1.85],0.8510976582152399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,21249,44,1.08 [0.44-2.64],0.873284451991241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,20668,42,0.95 [0.28-3.19],0.935629223801935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,21257,44,0.46 [0.23-0.93],0.0307129956229889
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,23920,49,0.84 [0.36-1.99],0.6943719571218641
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,20778,43,0.98 [0.64-1.48],0.9067737310859932
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,24307,49,2.32 [1.11-4.84],0.025677791504886
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,20778,43,1.57 [0.84-2.93],0.1604604291360234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,21165,44,1.64 [1.01-2.66],0.0440254941911888
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,24596,47,2.97 [1.28-6.86],0.0109077528552702
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,24660,49,2.14 [1.00-4.57],0.0494017974611979
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,21257,44,1.98 [0.75-5.20],0.1667350829837176
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,24385,49,1.20 [0.79-1.81],0.3859191080560404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,24515,49,2.27 [0.94-5.53],0.0699339094371445
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,20601,42,0.77 [0.47-1.28],0.3146574371739995
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,20778,43,0.98 [0.67-1.43],0.9138129048730544
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,24072,47,0.94 [0.71-1.26],0.6938545133626113
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,21282,44,1.15 [0.78-1.67],0.4821072849881769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,24722,48,6.94 [2.91-16.56],1.246041571459258e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,20594,43,1.03 [0.70-1.53],0.8722617322499868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,20778,43,1.11 [0.80-1.55],0.5349953139018119
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AFM,Afamin,21282,44,0.98 [0.22-4.40],0.9788174605958846
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,24271,49,1.21 [0.84-1.73],0.3000036935816645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,20601,42,1.15 [0.83-1.59],0.4052543994706656
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,24430,47,1.48 [0.79-2.75],0.2215668093186146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,23730,49,1.03 [0.80-1.33],0.8161508755801418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,23889,49,0.99 [0.65-1.52],0.9781307325941928
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,24596,47,3.46 [1.94-6.17],2.51092140676616e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,24802,48,1.32 [0.83-2.10],0.2369763376139483
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,21262,44,1.55 [0.51-4.68],0.4402485400367849
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,24515,49,1.00 [0.73-1.37],0.994554755766996
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,24515,49,1.04 [0.72-1.50],0.84652131793959
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,20668,42,2.50 [1.36-4.60],0.003293580756499
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,20668,42,1.92 [0.83-4.44],0.1273888859627051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,21141,44,0.99 [0.65-1.51],0.9758947232433444
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,21262,44,2.68 [1.00-7.23],0.0509933587576757
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,24456,48,0.92 [0.70-1.21],0.5625644128058735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",20672,43,1.25 [0.96-1.63],0.0927209009413847
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,23920,49,1.18 [0.73-1.89],0.4982855642679291
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,20668,42,0.79 [0.43-1.44],0.4394722159805553
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",24341,49,0.95 [0.75-1.21],0.6989378869460687
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,24515,49,0.94 [0.63-1.38],0.7439090684729119
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",21200,44,0.95 [0.72-1.24],0.6941456344695269
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,20778,43,1.94 [0.76-4.94],0.1653072339416385
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,23920,49,0.91 [0.65-1.27],0.5859938761084271
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,20672,43,0.72 [0.42-1.25],0.2408776542298225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,24072,47,1.02 [0.63-1.65],0.9293154953346392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,20648,42,0.89 [0.57-1.38],0.5982075054319997
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,23928,49,0.85 [0.59-1.24],0.4094522938849206
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,21224,44,0.86 [0.69-1.08],0.1882808736342878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,23793,49,0.66 [0.42-1.04],0.0714032670171034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,24797,49,7.64 [2.54-23.01],0.0003018358141591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,24494,48,1.25 [0.82-1.90],0.3077193619278708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",21141,44,1.12 [0.67-1.88],0.6610992536615341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",24465,49,1.10 [0.77-1.56],0.6006851896278529
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",21224,44,0.76 [0.39-1.46],0.404348645940968
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,20858,44,0.89 [0.45-1.78],0.7470332867581133
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,20648,42,1.18 [0.93-1.49],0.1801136901553606
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",24385,49,1.17 [0.95-1.43],0.1403431706223617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,24057,47,1.87 [1.25-2.81],0.0025087657501909
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,24691,48,5.39 [1.60-18.15],0.0065145135574715
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,21249,44,1.89 [0.61-5.86],0.2708489696386617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,23928,49,0.95 [0.64-1.40],0.7826882271745773
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,20672,43,1.01 [0.58-1.76],0.981305946620672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,24385,49,0.80 [0.26-2.43],0.6926895096754437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,24057,47,1.15 [0.68-1.94],0.6114683692326891
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,20778,43,0.68 [0.35-1.32],0.2521723881232951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,21074,44,1.20 [0.71-2.04],0.4908289693844893
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,21200,44,1.44 [0.99-2.11],0.0581724732242378
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,19929,43,1.14 [0.65-2.00],0.6380153253405927
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,23590,47,1.41 [0.82-2.42],0.2135010595441762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,22850,45,1.49 [0.87-2.54],0.1447249840057356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,24400,48,1.97 [1.07-3.61],0.0282697266616606
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,24419,47,0.85 [0.63-1.14],0.2782109999617546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,24722,48,1.93 [1.09-3.43],0.0252263021478103
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,24153,47,2.93 [1.27-6.74],0.0115495736910095
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,24515,47,1.59 [0.84-2.99],0.1529629031010508
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,24489,48,3.40 [1.78-6.49],0.0002129669635646
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,24561,47,2.14 [1.25-3.66],0.0053358137008221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,24722,48,1.38 [0.72-2.62],0.3304272329089275
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,20594,43,0.88 [0.55-1.40],0.5840592330890979
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,20648,42,0.73 [0.50-1.07],0.1093482895594429
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,20501,41,1.08 [0.64-1.84],0.7658034593920016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,23920,49,1.16 [0.78-1.72],0.4552530267212209
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,20668,42,1.25 [0.70-2.24],0.4488913747736073
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,24515,48,1.59 [0.68-3.72],0.2900277375927301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,20649,43,1.36 [0.83-2.22],0.2289345235305192
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,23928,49,0.97 [0.70-1.35],0.867106621938541
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,24451,49,0.88 [0.61-1.25],0.4715788053939871
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,20372,42,1.15 [0.77-1.69],0.4964856836245707
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,24701,49,0.74 [0.52-1.06],0.1053398227984925
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,24391,49,0.82 [0.57-1.17],0.2647877302801983
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,23855,49,1.01 [0.44-2.35],0.9808158254457748
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],24057,47,1.12 [0.74-1.70],0.585640142106052
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,24560,48,2.39 [1.07-5.36],0.033670096853329
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,21141,44,0.85 [0.59-1.22],0.3766983413323196
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,20672,43,0.62 [0.31-1.23],0.1696603431109623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,21165,44,0.89 [0.61-1.30],0.5410898109777483
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,21200,44,0.69 [0.36-1.34],0.270674930174139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,24385,49,1.42 [0.93-2.18],0.1058887007577101
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,21105,44,1.52 [0.72-3.22],0.2711071373351621
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,24657,48,0.69 [0.44-1.08],0.1067888147842584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,24515,49,1.21 [0.75-1.95],0.4243666789289485
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,21282,44,0.61 [0.20-1.86],0.3842513483844146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,21262,44,1.51 [0.84-2.70],0.1658633838813001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,21282,44,1.60 [0.90-2.83],0.1064963286826046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,21262,44,2.70 [0.74-9.85],0.1317165705582451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,20668,42,1.00 [0.50-2.00],0.9964682583249984
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,21240,44,0.94 [0.45-1.97],0.8776269848445061
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,20283,42,0.68 [0.29-1.56],0.3599706424436326
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,21282,44,1.10 [0.79-1.52],0.5748746702771291
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,21262,44,2.07 [0.68-6.31],0.201944974734609
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,24494,48,1.08 [0.54-2.19],0.8210381686541771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,21262,44,1.20 [0.81-1.78],0.3637970414642004
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,24531,48,1.19 [0.46-3.03],0.7211148352236698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,24452,48,0.75 [0.51-1.11],0.1574294460991298
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,20778,43,0.87 [0.67-1.12],0.2696391100104184
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,24321,49,1.15 [0.68-1.94],0.6094387336121557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,20858,44,1.06 [0.70-1.62],0.7679120932728511
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,24385,49,0.95 [0.55-1.64],0.8521423602625711
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,21165,44,0.97 [0.74-1.26],0.8109741266200352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,21224,44,0.85 [0.55-1.29],0.4370473536922992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,24386,47,1.42 [0.88-2.27],0.1511843967308917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",21141,44,0.58 [0.26-1.33],0.2014265110871427
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,23920,49,0.77 [0.45-1.32],0.3447105302899858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,23920,49,0.78 [0.50-1.22],0.2678207218896415
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,20858,44,1.52 [0.89-2.62],0.1271838115643641
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,20778,43,0.81 [0.57-1.17],0.2637891693486175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,20501,41,1.14 [0.79-1.64],0.4970548386743473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,21200,44,0.82 [0.60-1.12],0.2112809649173079
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,21224,44,1.02 [0.75-1.38],0.9229873678214856
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,24494,49,0.88 [0.69-1.13],0.315511720248562
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,20601,42,0.89 [0.59-1.36],0.6038027050567962
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,20601,42,1.21 [0.61-2.40],0.5855415052184718
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,23928,49,0.43 [0.19-0.98],0.0441990608729296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,20594,43,0.74 [0.47-1.17],0.201812997547167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,20594,43,0.56 [0.26-1.19],0.129163832496245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,20601,42,0.83 [0.47-1.46],0.5246497103825278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,24057,47,1.35 [0.77-2.35],0.2956552138178369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,20594,43,1.14 [0.69-1.89],0.6108543892368172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,24494,48,0.85 [0.48-1.50],0.5782898548184403
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,24385,49,0.82 [0.52-1.30],0.4030028034082002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,24560,48,2.46 [1.32-4.59],0.004658718035038
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,20601,42,1.22 [0.86-1.73],0.2748035744732213
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,24057,47,1.09 [0.65-1.83],0.7364712563737705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,21072,44,0.74 [0.39-1.41],0.3561429560056144
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,24348,49,0.88 [0.57-1.36],0.5676461852991259
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,24348,49,1.72 [0.78-3.81],0.1787897916217458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,21262,44,4.98 [1.88-13.18],0.001227972189904
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,21257,44,1.39 [0.53-3.62],0.5014569613174003
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,21224,44,0.71 [0.47-1.10],0.1230107512870926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,20668,42,0.84 [0.63-1.13],0.2449819408120435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,20594,43,0.83 [0.58-1.18],0.3001550594119517
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,23928,49,0.88 [0.57-1.36],0.5651121028413604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,20501,41,0.60 [0.22-1.62],0.3140687920133483
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,21165,44,0.98 [0.71-1.37],0.922632800530624
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,23920,49,0.98 [0.64-1.50],0.9367904304933944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,24550,47,1.27 [0.89-1.82],0.1912430648118575
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,20594,43,0.85 [0.43-1.69],0.6514267672109761
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,20594,43,1.05 [0.41-2.69],0.9196648390860458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,20594,43,0.90 [0.42-1.96],0.7994326346376854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,20501,41,0.81 [0.37-1.75],0.5880519870599704
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,20594,43,1.07 [0.70-1.64],0.7586971108467071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",20594,43,0.60 [0.28-1.27],0.1791931261331685
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",24596,47,0.92 [0.73-1.15],0.4480118205904769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",23928,49,0.85 [0.45-1.61],0.6216574598256492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,23920,49,0.89 [0.47-1.70],0.7277750128493392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,24385,49,1.17 [0.47-2.91],0.7356771954511411
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,23881,49,0.93 [0.63-1.37],0.6972983014963392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,20668,42,0.81 [0.53-1.23],0.3140702371179102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,20594,43,0.86 [0.62-1.18],0.348683606880536
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,21165,44,1.69 [1.14-2.49],0.0083064281246768
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",21282,44,1.62 [0.28-9.21],0.5887290953086176
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,23928,49,0.82 [0.58-1.15],0.2514770993161941
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,20601,42,0.57 [0.38-0.86],0.0077111497547042
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,21224,44,0.68 [0.34-1.36],0.2711989187209694
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,21200,44,1.09 [0.69-1.71],0.7104458157657975
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,24494,49,0.83 [0.64-1.08],0.1568697857518874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,24560,48,6.35 [3.38-11.90],8.378212540942786e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,21224,44,1.00 [0.60-1.67],0.994530291619121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,23753,47,0.94 [0.66-1.32],0.699559271740807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,21282,44,1.83 [1.38-2.42],2.688910645228904e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,20594,43,1.05 [0.25-4.48],0.9470742178603866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",20668,42,3.62 [1.70-7.71],0.0008539217806924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",24596,47,5.97 [2.86-12.47],1.988485678359237e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",24494,48,1.88 [0.68-5.17],0.2229943983450071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,20648,42,0.82 [0.28-2.44],0.7210810668529857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,24494,49,0.81 [0.57-1.16],0.2544427157432446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,24307,49,1.23 [0.64-2.35],0.5359516521157746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,20648,42,0.97 [0.54-1.76],0.9297045182408312
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,24072,47,1.23 [0.62-2.46],0.5473409232370856
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,23920,49,1.09 [0.74-1.61],0.6705417901223599
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,23920,49,3.84 [2.45-6.04],5.0790068172729325e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,24494,49,0.89 [0.70-1.12],0.3071204882016295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,21200,44,1.13 [0.78-1.63],0.5249067555208218
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,20672,43,0.89 [0.60-1.32],0.569947094077352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,23891,49,0.86 [0.65-1.15],0.3120577435001097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,24494,48,2.86 [1.08-7.59],0.0348225093699808
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,24348,49,0.70 [0.34-1.44],0.3307646636822691
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",21257,44,1.53 [0.69-3.37],0.2946240355201353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",20601,42,0.84 [0.45-1.57],0.5852797308040316
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,20864,44,3.19 [1.13-9.00],0.0284474025082765
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,21165,44,1.92 [1.47-2.52],1.8429098914219028e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,21200,44,0.92 [0.69-1.23],0.5856605895355484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",24494,49,1.23 [0.67-2.24],0.5007963308682937
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,20648,42,1.42 [0.98-2.06],0.0652026246708325
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,20501,41,0.76 [0.44-1.32],0.3267281629679471
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,21141,44,1.17 [0.66-2.06],0.6000737565472876
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,24494,49,0.93 [0.71-1.23],0.6256086761462867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,21249,44,0.65 [0.48-0.89],0.0073326123123088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,20668,42,0.94 [0.58-1.54],0.8128967129663812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,20501,41,0.69 [0.32-1.49],0.3418670860084021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,21249,44,1.57 [1.14-2.16],0.005719409042543
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,23887,49,1.27 [1.04-1.56],0.0183561697831711
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,20601,42,0.64 [0.40-1.04],0.0704256809676462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,20594,43,1.36 [0.45-4.15],0.5884395097383108
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,24494,49,0.92 [0.63-1.35],0.6785985061324198
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,24494,48,0.75 [0.56-1.01],0.055686391465674
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,23920,49,0.78 [0.52-1.18],0.2439498694128049
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,24797,49,1.13 [0.53-2.42],0.7504023786089771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,20648,42,1.29 [0.66-2.53],0.4536872769379316
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,20601,42,1.21 [0.88-1.68],0.2444464019731632
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,21200,44,0.55 [0.25-1.22],0.1433004580032431
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,24494,48,1.13 [0.79-1.62],0.507179377729418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,20778,43,0.71 [0.27-1.87],0.4890830140066781
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,24307,49,1.00 [0.58-1.72],0.9959739428152712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,24025,47,0.71 [0.40-1.27],0.2530733248824632
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,20778,43,2.05 [0.82-5.17],0.1262363920958275
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,21257,44,0.95 [0.41-2.22],0.9079303716550554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,20648,42,1.37 [0.77-2.46],0.2836507308069566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,24072,47,2.46 [0.84-7.19],0.1000258533069598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,20601,42,1.03 [0.61-1.73],0.903664108362206
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,20668,42,0.79 [0.47-1.34],0.3902708980562079
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,19934,41,0.76 [0.57-1.01],0.0587930498265173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,24454,48,1.07 [0.73-1.57],0.731001176453467
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,21224,44,1.74 [1.22-2.47],0.0020949912449426
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,20967,44,0.86 [0.67-1.11],0.2535157671137129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,20858,44,1.07 [0.43-2.71],0.8795279669600689
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,20601,42,1.86 [1.04-3.33],0.0367810072772422
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,20594,43,0.89 [0.45-1.74],0.7326979504558131
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,20594,43,1.41 [0.67-2.95],0.3629688564119107
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,23928,49,0.88 [0.50-1.56],0.6647785867383093
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,20601,42,1.08 [0.55-2.11],0.8190906102805366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,21224,44,0.93 [0.44-2.01],0.8628861741564551
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BSG,Basigin,24754,48,3.24 [0.96-10.90],0.0572488383496726
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BSND,Barttin,20501,41,0.22 [0.07-0.69],0.0086924349429805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,24739,49,1.05 [0.60-1.85],0.8657906696842497
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,24739,49,1.62 [1.16-2.26],0.0043626133193415
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,23920,49,0.71 [0.49-1.04],0.0798629936421406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,21282,44,1.24 [0.31-4.91],0.7628268601508197
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,20501,41,1.03 [0.74-1.43],0.8656723522386495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,21103,44,0.83 [0.38-1.80],0.63136395107612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,24596,47,5.90 [2.70-12.88],8.28463514360259e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,24494,49,2.17 [1.31-3.58],0.0025357607160569
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,20501,41,1.21 [0.61-2.38],0.5840616424978446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,23928,49,1.25 [0.91-1.72],0.1717895519549029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,20594,43,1.25 [0.53-2.93],0.6123932989139207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,24672,48,1.63 [0.56-4.76],0.373930523598829
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",21224,44,1.11 [0.77-1.62],0.5699639149652139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,20648,42,0.27 [0.13-0.57],0.0005409574176126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,24560,48,1.52 [0.88-2.65],0.1363887400787059
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,20778,43,0.56 [0.28-1.10],0.0910841282240646
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,21224,44,1.38 [0.63-3.00],0.4184115279471238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,20739,43,0.78 [0.45-1.35],0.3752154839560546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,21282,44,1.99 [0.84-4.72],0.1205023642963304
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,21246,44,7.12 [1.70-29.73],0.0071168536288982
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,21282,44,2.29 [0.66-7.91],0.191556691657949
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C2,Complement C2,24531,48,5.57 [1.70-18.19],0.004468353740399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,23881,49,0.62 [0.33-1.17],0.1430264722471134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,20672,43,0.68 [0.36-1.29],0.2407017152864601
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C3,Complement C3,20221,41,0.94 [0.47-1.85],0.8472958600340506
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,24550,47,2.38 [1.36-4.17],0.002300978792112
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C5,Complement C5,21282,44,0.88 [0.14-5.64],0.8890589351487806
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,20795,43,1.36 [0.54-3.43],0.5128826968534205
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,21200,44,0.72 [0.16-3.13],0.6585242753603998
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,21282,44,1.61 [0.64-4.03],0.3114414226282008
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,21262,44,2.95 [1.65-5.26],0.0002530010245785
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,21165,44,1.24 [0.89-1.74],0.2034719181542873
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,23929,47,1.33 [0.88-2.00],0.1721145490001642
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,23920,49,1.17 [0.58-2.35],0.659012476372747
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,24385,49,2.19 [1.27-3.75],0.0045223569382522
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,24222,49,0.89 [0.70-1.12],0.3104681415501991
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,24722,48,1.32 [0.67-2.59],0.4179995066373019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,24423,48,1.14 [0.81-1.61],0.4519762270876153
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,24755,49,1.27 [0.88-1.85],0.2038289298793361
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,24797,49,1.37 [0.50-3.80],0.5431437328808563
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",24072,47,1.10 [0.84-1.42],0.4908642685226625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,24416,47,0.86 [0.59-1.24],0.4202167800790674
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,20858,44,0.83 [0.34-2.05],0.6915882259105686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,20648,42,2.01 [1.12-3.60],0.0187585049969608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,24722,48,1.14 [0.65-2.01],0.6417791264614188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,20672,43,0.85 [0.52-1.38],0.5137103866374542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,20601,42,1.34 [0.61-2.94],0.4629118441532565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,20594,43,0.49 [0.22-1.12],0.0895009847668743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,20601,42,1.08 [0.68-1.74],0.7357304632003017
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,21224,44,0.88 [0.63-1.24],0.4789083628542934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,20732,43,0.87 [0.66-1.15],0.3228600505430925
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,20672,43,0.79 [0.36-1.73],0.5490629863428069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,24385,49,2.73 [1.66-4.49],7.723343982691807e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,23928,49,1.36 [0.62-3.01],0.4458920476306603
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,24301,49,1.34 [0.99-1.82],0.0553580381918256
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,21200,44,1.44 [0.80-2.58],0.2232402316695463
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,24652,48,0.95 [0.74-1.21],0.6765657165115416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,20668,42,0.93 [0.63-1.38],0.7187944191677742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,20594,43,1.01 [0.46-2.22],0.97217932779841
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,23920,49,0.98 [0.56-1.73],0.9514988830176574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,20672,43,0.43 [0.22-0.87],0.0183178240647171
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,21224,44,1.03 [0.79-1.34],0.8515583463429913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,24445,48,6.76 [2.02-22.62],0.0019207078713522
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,24350,47,1.42 [0.96-2.09],0.0755746928943208
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,21141,44,1.20 [0.63-2.30],0.5798279294071589
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,21200,44,0.85 [0.55-1.30],0.4470306920600624
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,23928,49,0.90 [0.55-1.47],0.6743185022022544
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,20672,43,0.63 [0.30-1.35],0.2397439642074046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,23928,49,1.14 [0.81-1.61],0.4379985055312811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,23928,49,0.89 [0.63-1.26],0.5169973356199106
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,24494,49,0.70 [0.48-1.04],0.0763849369771782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,24797,49,0.87 [0.66-1.15],0.3373714076201168
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,20858,44,0.81 [0.65-1.01],0.0587701704942486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,21200,44,0.77 [0.54-1.08],0.1324492453629752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,24659,48,1.04 [0.70-1.54],0.8398721054860139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,20648,42,0.68 [0.40-1.13],0.1344476639345508
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,20594,43,0.71 [0.33-1.51],0.3719039407881783
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAT,Catalase,20937,44,1.20 [0.73-1.95],0.4752248311358649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,24487,49,0.94 [0.66-1.36],0.753342003413352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,20601,42,0.57 [0.35-0.93],0.0244607095113886
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,24722,48,1.21 [0.56-2.59],0.6279896168509818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,20668,42,1.05 [0.60-1.85],0.8563931287189962
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,20594,43,1.26 [0.69-2.29],0.45239822123497
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,24348,49,0.92 [0.65-1.30],0.6252485388492303
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,21200,44,0.85 [0.46-1.56],0.5983932451156451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,21141,44,0.71 [0.38-1.31],0.2718124111773026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,20672,43,1.88 [0.72-4.95],0.1989674744988702
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,21224,44,0.73 [0.45-1.16],0.1794196676292915
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,24515,49,2.74 [1.38-5.44],0.003957709001127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,20668,42,1.19 [0.75-1.87],0.4586250078424375
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,24802,48,1.72 [0.91-3.24],0.0938180593217388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,24762,48,1.21 [0.85-1.73],0.2987698967592025
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,24400,48,1.83 [1.18-2.84],0.0073195223157509
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,24797,49,1.98 [1.23-3.18],0.004754128373548
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,24797,49,1.67 [1.06-2.62],0.0263365946240014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,24432,47,1.42 [1.08-1.86],0.0109204647390421
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,24137,48,1.43 [1.15-1.79],0.0014720308479038
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,24739,49,0.91 [0.72-1.16],0.4555913626359522
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,24307,49,1.84 [1.20-2.83],0.0053021089307024
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,24802,48,1.30 [1.03-1.64],0.0278613253730061
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,24596,47,1.23 [0.70-2.15],0.4774115081090152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,24207,47,1.95 [1.34-2.84],0.000519028041074
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,24596,47,1.86 [1.04-3.32],0.0362396754773265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,24561,47,1.40 [1.04-1.88],0.0269586337975579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,24802,48,1.28 [0.78-2.10],0.3310614435123987
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,24494,49,1.11 [0.87-1.43],0.3859049337565752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,24515,49,1.31 [0.88-1.96],0.1829789550436454
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,24421,49,1.42 [0.98-2.05],0.0604612484436241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,24494,49,1.31 [1.06-1.61],0.0120046491042459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,24508,47,1.32 [0.99-1.76],0.055744260098872
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,24560,48,1.06 [0.83-1.36],0.6302605362268114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,24494,49,1.21 [0.84-1.74],0.3077649262401492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,24691,48,1.12 [0.74-1.70],0.577935756502473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,24351,49,1.06 [0.77-1.47],0.7198491914565993
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,24494,47,0.71 [0.46-1.10],0.1240004924968391
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,24756,49,3.84 [2.34-6.30],1.039290125733736e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,24722,48,1.18 [0.65-2.14],0.5767251407517291
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,24494,48,0.52 [0.27-1.00],0.0498226361905266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,20858,44,1.18 [0.53-2.58],0.6876215407040279
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,20648,42,1.00 [0.73-1.37],0.98936031919705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,24348,49,0.74 [0.44-1.26],0.2696626124356659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,23920,49,1.10 [0.64-1.89],0.7292160248103912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,21165,44,0.70 [0.37-1.30],0.2575274738971015
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,24494,48,1.28 [0.60-2.74],0.5293026272053266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,23951,47,3.83 [2.51-5.85],5.343396427463863e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,24802,48,1.66 [0.99-2.78],0.055590054931057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,24560,48,2.97 [1.85-4.79],7.350204454557424e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,24494,48,0.70 [0.24-2.08],0.5232516364543627
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,20672,43,0.91 [0.40-2.05],0.8184604245825018
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,24459,48,1.13 [0.90-1.41],0.2888577430208245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,24550,47,0.89 [0.31-2.58],0.8306397231511178
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,20594,43,0.71 [0.29-1.76],0.4594249659982775
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,24494,49,3.72 [2.03-6.83],2.2631882024046208e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,24413,49,1.43 [0.72-2.85],0.311920948581139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,23970,49,1.16 [0.60-2.23],0.6659486955993433
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,24540,49,1.07 [0.57-2.01],0.8360046239628621
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,24802,48,0.96 [0.51-1.79],0.8901293256293853
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,20648,42,0.51 [0.25-1.04],0.0641981192613915
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,24802,48,2.96 [1.33-6.58],0.0076148444638379
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,21249,44,1.29 [0.63-2.61],0.4880930450588127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,24550,47,1.22 [0.64-2.33],0.5525037678878186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,24348,49,2.37 [1.45-3.89],0.0006009796750709
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,24476,47,2.67 [1.30-5.48],0.0073688384289897
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,23920,49,2.71 [1.63-4.50],0.0001209925538595
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,24515,49,1.12 [0.76-1.64],0.5803628944789485
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,20778,43,4.11 [1.79-9.44],0.0008720963238831
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,24739,49,2.61 [1.40-4.87],0.0025090509186226
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,24646,47,2.47 [1.41-4.33],0.0016216195718461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,24722,48,1.51 [0.95-2.38],0.0786256801557794
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,24494,48,1.65 [0.86-3.19],0.13352338303197
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,24385,49,4.14 [2.28-7.51],2.9619400722505465e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,24550,47,1.58 [1.09-2.31],0.0165474198884485
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,24644,49,1.61 [0.58-4.50],0.3620477270547406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,20648,42,1.24 [0.68-2.29],0.4818354843963123
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,24385,49,2.22 [1.15-4.29],0.0174123518851273
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,20601,42,0.85 [0.34-2.16],0.7376925815349848
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,20858,44,0.62 [0.23-1.69],0.3482881765177786
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,20648,42,0.87 [0.59-1.30],0.5034573499616717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,24450,49,1.75 [0.94-3.25],0.076523928506046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,24473,47,1.08 [0.66-1.79],0.7516440045014425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,24802,48,0.92 [0.67-1.27],0.6291202046952588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,24315,48,2.36 [1.28-4.33],0.0056998059931804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,24561,47,1.83 [0.77-4.36],0.1747092747764231
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,24691,48,1.23 [0.58-2.62],0.5845307397619802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,23623,44,2.52 [1.58-4.04],0.0001159144971412
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,24425,47,6.31 [1.54-25.86],0.0104615150619172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,23583,48,4.22 [2.13-8.37],3.817362709664729e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,21172,44,0.32 [0.17-0.59],0.0002591880946269
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,24754,48,0.75 [0.47-1.19],0.2238618651950874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,24307,49,0.63 [0.39-1.01],0.0548877461474927
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,24381,48,0.82 [0.62-1.08],0.1612074070819302
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,20614,42,1.47 [0.79-2.75],0.2268528211226836
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,24494,49,1.83 [1.04-3.22],0.0370360978365429
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,20778,43,3.94 [2.42-6.43],4.02092867765556e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,24739,49,4.61 [2.65-8.03],6.276535774616488e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,24802,48,3.35 [2.26-4.98],2.184243223784699e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,21257,44,5.93 [3.70-9.50],1.404205935813703e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,20858,44,0.43 [0.17-1.14],0.0897717006054787
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,24494,49,5.34 [2.95-9.67],3.3466193973589446e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,24494,49,0.30 [0.14-0.64],0.0020668134306117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,21165,44,1.68 [0.65-4.35],0.2810253143243134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,24739,49,1.36 [0.82-2.25],0.2339311651885026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,23529,47,4.27 [2.29-7.94],4.652741321696264e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,24494,48,2.33 [0.76-7.13],0.1397294351266227
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,24494,48,2.50 [0.92-6.81],0.0740122909723986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,21223,44,1.44 [0.87-2.37],0.1579094515423623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,21200,44,1.09 [0.33-3.58],0.8873064953638278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,20501,41,1.04 [0.67-1.62],0.864694185298736
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,20501,41,1.20 [0.65-2.22],0.5625342230642076
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,21129,44,0.85 [0.56-1.30],0.461299993088806
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,23920,49,0.92 [0.60-1.42],0.7054797366400638
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,24550,47,0.88 [0.65-1.19],0.4073413279285003
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,21165,44,0.97 [0.73-1.28],0.8184688113281955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,24348,49,1.67 [1.09-2.54],0.0174387570494995
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,23641,45,1.68 [1.08-2.60],0.0207516126065183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,24692,49,1.03 [0.67-1.58],0.8933173016247732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,24515,49,1.19 [0.83-1.69],0.3432265273711824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,24515,49,2.09 [1.07-4.08],0.0303637106024138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,20858,44,1.28 [0.52-3.17],0.5905684448391129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,21200,44,0.73 [0.24-2.27],0.5891390163516156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,24739,49,2.53 [1.39-4.59],0.0023295353160117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,20601,42,0.71 [0.35-1.47],0.3601202223677263
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,24797,49,2.12 [0.99-4.51],0.0525787171759425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,24515,49,1.44 [0.76-2.76],0.2648592452755817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,23928,49,1.88 [1.34-2.63],0.0002513257787276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,24385,49,1.20 [0.90-1.61],0.2106647383961986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,24515,49,1.69 [0.86-3.34],0.1309113701472966
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,20501,41,1.23 [0.54-2.76],0.6230294124921361
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,21224,44,0.36 [0.19-0.68],0.0016660862434924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,20601,42,1.06 [0.63-1.81],0.8189880334020674
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,24385,49,0.97 [0.77-1.22],0.7784949195495783
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,24385,49,0.82 [0.64-1.05],0.110263957439039
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,24385,49,1.40 [0.70-2.82],0.3411392540880595
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,24520,47,1.62 [0.63-4.16],0.3125128276420057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,24721,48,2.23 [1.27-3.91],0.0052010026016769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,24512,47,2.83 [0.95-8.39],0.0606976353681599
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,21165,44,1.13 [0.81-1.58],0.479552092373155
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,20858,44,0.97 [0.63-1.49],0.88872393731723
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,21165,44,1.33 [0.66-2.66],0.4211625207238825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,20858,44,1.82 [1.25-2.64],0.0017144798194317
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,24494,49,1.19 [0.90-1.58],0.2144519546571414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,23920,49,0.90 [0.52-1.57],0.7212819668694961
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,23570,48,1.46 [1.00-2.12],0.0483889061707188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,21249,44,0.78 [0.39-1.56],0.4802497025560904
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,24072,47,1.16 [0.71-1.88],0.5603802599902824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,20648,42,1.06 [0.52-2.16],0.8626139757345359
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,24072,47,1.57 [0.93-2.66],0.0923655523190246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,21249,44,1.44 [0.90-2.30],0.1251633212986804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,24752,49,1.32 [0.86-2.03],0.2019469948480188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,20778,43,0.74 [0.26-2.07],0.5594872388555392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,20648,42,1.33 [0.67-2.65],0.4180421952546416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,20601,42,0.84 [0.47-1.53],0.5791571132794946
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,20858,44,1.22 [0.76-1.95],0.4207834015956255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,20858,44,0.87 [0.56-1.37],0.5543253472565876
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,20594,43,0.95 [0.49-1.85],0.8795485335075733
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,20501,41,1.49 [0.93-2.39],0.097935556328751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,24057,47,0.71 [0.40-1.25],0.2299313084843613
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,20668,42,0.86 [0.58-1.29],0.4677071395343957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,23920,49,0.87 [0.62-1.24],0.4538723589129584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,20858,44,1.34 [0.90-1.98],0.1462769193298628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,20501,41,1.32 [0.65-2.68],0.4494303204059078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,23879,47,0.85 [0.58-1.24],0.399986552668113
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,23920,49,1.00 [0.67-1.49],0.9921924496470552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,23928,49,0.80 [0.53-1.21],0.290045887178482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,24537,49,1.08 [0.80-1.47],0.6112705461563026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,24385,49,1.02 [0.65-1.61],0.9174300444915032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,24385,49,1.04 [0.73-1.49],0.8316311116635546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,23928,49,0.65 [0.43-0.98],0.0401957852540329
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,21165,44,0.57 [0.39-0.84],0.0049679002355496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,20891,43,3.22 [1.38-7.53],0.006911606887614
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,23920,49,1.41 [0.92-2.14],0.1119970279596541
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,21282,44,1.65 [0.56-4.85],0.3631644021058426
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,20059,39,4.55 [1.46-14.19],0.0089476636616793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,21130,44,1.44 [0.82-2.53],0.2084162692318814
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,21243,44,1.76 [1.12-2.76],0.0141574162035784
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,20994,44,1.53 [0.75-3.10],0.2426673971528175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,21282,44,4.81 [1.27-18.28],0.0209813490642696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFP,Properdin,21282,44,1.23 [0.43-3.48],0.6980981761135138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,24494,48,1.38 [1.12-1.70],0.0021932653979404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,21262,44,0.88 [0.44-1.75],0.7063853219266442
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,20672,43,1.00 [0.47-2.13],0.9916324433474294
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,24515,49,2.07 [1.18-3.60],0.0105268026994046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,23920,49,0.76 [0.49-1.19],0.2346931036546955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,20778,43,1.34 [0.75-2.39],0.3167414495835315
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",21200,44,2.07 [1.29-3.34],0.0027943787432858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,21141,44,1.91 [0.99-3.66],0.0521658760533204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,24072,47,1.76 [0.95-3.29],0.0746507338701484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,21249,44,1.31 [0.97-1.77],0.0755404213854351
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,24650,48,1.91 [1.03-3.56],0.041418448467903
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,23907,47,1.16 [0.85-1.59],0.3544263426205997
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,24590,49,0.94 [0.81-1.08],0.3974144255881999
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,24517,48,2.15 [1.07-4.34],0.032224321191788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,20672,43,0.89 [0.54-1.46],0.6455989980198049
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,24348,49,0.94 [0.68-1.29],0.6894598748358685
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,21257,44,0.75 [0.45-1.23],0.2534347714120047
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,20601,42,1.00 [0.68-1.47],0.9970179333525544
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,24561,47,2.11 [0.96-4.67],0.0643316179800021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,24515,49,0.79 [0.50-1.25],0.3168968581109124
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,20672,43,1.46 [0.81-2.64],0.203391260000683
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,24550,47,0.93 [0.62-1.40],0.7347307323531576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,21249,44,1.08 [0.64-1.81],0.7734266643730776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,20858,44,0.68 [0.31-1.50],0.3411808547020755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,21165,44,0.89 [0.66-1.19],0.4291596930438945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,20672,43,1.44 [0.86-2.43],0.1663084004198152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,24666,48,3.47 [1.80-6.70],0.0002046301181807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,21249,44,1.21 [0.74-1.95],0.446668360134038
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",24378,47,0.84 [0.60-1.18],0.3131398320995358
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,20501,41,1.04 [0.69-1.56],0.8532127863886417
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,24479,48,0.83 [0.55-1.23],0.3454900660262144
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,24348,49,1.10 [0.55-2.18],0.7921296522536908
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,24447,48,0.69 [0.41-1.17],0.1724146819243474
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,20648,42,3.78 [1.87-7.65],0.0002087923869994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,24494,48,3.79 [1.87-7.64],0.0002046220581827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,24072,47,4.93 [2.76-8.81],7.026399905851299e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,24739,49,0.80 [0.61-1.04],0.0894848971469117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,20672,43,1.30 [0.83-2.02],0.2502817873193053
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,20797,43,0.81 [0.21-3.10],0.7550089635840683
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,24494,49,0.89 [0.45-1.79],0.7461448917589479
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,24494,49,1.04 [0.61-1.79],0.8775506849796735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,24494,49,1.03 [0.70-1.54],0.8670161547223658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,24494,49,2.18 [1.06-4.45],0.0333966678109535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,21214,44,0.93 [0.52-1.67],0.8149540287100681
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,24425,49,1.42 [0.62-3.23],0.4049183232787976
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,23920,49,1.60 [0.98-2.61],0.0614639183520749
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,24802,48,1.86 [1.05-3.27],0.0321093465719567
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,20672,43,0.90 [0.45-1.77],0.7509734258090697
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,20672,43,1.62 [0.91-2.90],0.103830267147752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,20501,41,0.88 [0.44-1.76],0.7152293044524466
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,24494,49,0.95 [0.77-1.19],0.6783534794715461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,24722,48,4.37 [1.70-11.26],0.0022229757927534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,20672,43,1.53 [0.74-3.14],0.2487142702908559
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",24301,49,0.91 [0.70-1.18],0.484070586483174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,24456,48,1.36 [0.95-1.95],0.0896335885147461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,23881,49,1.26 [0.71-2.23],0.4233416554767799
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,23928,49,1.13 [0.71-1.78],0.6074213682813168
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,24802,48,1.14 [0.61-2.11],0.6898654154024385
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,21200,44,1.95 [1.03-3.68],0.0408121024029028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,24072,47,1.20 [0.72-2.00],0.4805437745893186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,21282,44,1.19 [0.60-2.36],0.627282890243618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,24476,49,0.99 [0.58-1.69],0.983364930192856
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,21257,44,0.84 [0.61-1.16],0.2873994894088278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,21141,44,0.85 [0.60-1.20],0.3491451131198966
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,24560,48,0.81 [0.48-1.36],0.4232975976937622
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,20601,42,1.10 [0.68-1.79],0.7004292200905953
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",20630,42,0.85 [0.59-1.24],0.3974291653126534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,24072,47,0.79 [0.47-1.33],0.3751563426919881
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,24385,49,0.88 [0.63-1.22],0.4415625908496241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNST,Consortin,24515,49,0.86 [0.68-1.08],0.1898932566997049
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,20601,42,0.94 [0.39-2.27],0.8968374325804521
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,24797,49,1.15 [0.48-2.80],0.752475365358829
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,24722,48,0.90 [0.51-1.59],0.711891360202644
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,24494,48,0.99 [0.49-2.00],0.9886707349593604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,24494,48,1.20 [0.41-3.49],0.7421025993313477
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,24573,49,0.52 [0.26-1.04],0.0635889526259404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,24494,49,1.26 [0.71-2.26],0.4329946041794489
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,20672,43,1.01 [0.77-1.34],0.921994836264444
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,21257,44,1.64 [0.93-2.88],0.0862760162377934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,21249,44,2.83 [1.11-7.21],0.0296113320777868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,24575,48,,
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,24797,49,4.28 [1.71-10.71],0.0018826355317183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,21165,44,2.33 [1.32-4.11],0.003368060175348
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,20672,43,0.84 [0.56-1.24],0.3818898737533229
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,20668,42,0.75 [0.51-1.11],0.1551338823587814
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,21249,44,2.54 [0.93-6.95],0.0693495666945083
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,24515,49,1.86 [1.03-3.36],0.0411690416014786
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,20823,44,0.95 [0.55-1.62],0.8418699885673433
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,20778,43,1.36 [0.69-2.69],0.3731761630643452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,24797,49,3.88 [2.26-6.66],9.127508782177688e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,24494,49,1.91 [1.24-2.95],0.0033940295974666
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,20858,44,1.11 [0.62-1.99],0.7199869063818686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,24476,47,6.68 [2.96-15.09],4.964407613491422e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,20668,42,0.93 [0.57-1.50],0.7612717885462534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,21141,44,0.66 [0.30-1.49],0.3188933757264685
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,24221,48,1.67 [0.80-3.52],0.1752782764799875
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,23798,47,0.89 [0.65-1.20],0.4399280059840462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',20594,43,0.57 [0.28-1.19],0.1361315005111512
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,23928,49,0.87 [0.48-1.58],0.6548587360363376
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",20668,42,1.25 [0.70-2.22],0.4509383144347771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,23994,48,0.96 [0.72-1.28],0.7757998752797766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,20601,42,0.79 [0.34-1.83],0.5872203519610418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",24385,49,1.03 [0.72-1.47],0.857758788017968
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,21257,44,0.65 [0.26-1.67],0.372111976216213
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,24797,49,1.47 [1.00-2.15],0.0478577167269577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,24650,49,1.04 [0.71-1.53],0.8343562667309186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,20365,43,0.79 [0.41-1.52],0.4756478182596428
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,24797,49,1.60 [1.11-2.30],0.0116679845308354
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,21240,44,0.83 [0.24-2.93],0.7752465550416239
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,24544,48,0.92 [0.49-1.74],0.8042664558969772
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,20501,41,0.96 [0.35-2.61],0.9399143454106036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,24634,48,1.14 [0.58-2.27],0.701420814787094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",20648,42,0.76 [0.25-2.29],0.6293562145975852
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,24739,49,0.86 [0.59-1.25],0.4210175055798716
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,21213,44,0.95 [0.47-1.93],0.8917168145921857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,20594,43,0.70 [0.31-1.59],0.3920263327427391
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,24679,47,1.25 [0.65-2.38],0.5037734943301566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,24550,47,0.99 [0.68-1.43],0.9425239944199412
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,21257,44,3.13 [1.29-7.57],0.0113843264552637
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,21177,44,2.71 [1.25-5.89],0.0118861642573899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,24560,48,0.78 [0.45-1.35],0.3674114362891865
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,23920,49,0.94 [0.69-1.27],0.6757600113917488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,24301,49,0.86 [0.62-1.19],0.3663800008871575
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,20501,41,0.69 [0.36-1.33],0.2652140294313265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,20501,41,1.65 [0.66-4.13],0.2866802574879245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,24148,47,1.44 [0.77-2.69],0.255806165017477
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,20778,43,1.95 [0.92-4.14],0.0812053154831555
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,24561,47,1.34 [0.84-2.15],0.2239663459092841
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,23879,49,1.00 [0.75-1.34],0.9867779639650944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,24476,47,2.96 [1.22-7.17],0.0161185602850389
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,24072,47,0.97 [0.63-1.48],0.8727213436472853
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,24596,47,3.20 [1.11-9.24],0.0319209805048078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,24348,49,1.92 [1.16-3.20],0.0119063390603278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,24722,48,1.21 [0.82-1.81],0.3372888446370173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,21056,44,0.20 [0.07-0.55],0.001833411968653
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,24510,47,0.87 [0.69-1.10],0.234060380484211
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,24596,47,2.54 [0.96-6.71],0.0605778413067934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,23762,46,1.05 [0.71-1.55],0.8039964373104492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,24797,49,0.54 [0.25-1.18],0.1249043981277207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,24348,49,1.82 [1.12-2.95],0.0160732551285998
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,20672,43,1.22 [0.73-2.02],0.4465809863547487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,24072,47,1.01 [0.80-1.28],0.9308969272979506
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,21257,44,0.75 [0.48-1.16],0.199055080747187
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,21200,44,0.88 [0.49-1.60],0.6813281206103419
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,21200,44,0.68 [0.50-0.91],0.0089804654193026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,20601,42,1.10 [0.77-1.57],0.6044452655782597
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,20668,42,0.87 [0.63-1.21],0.4154774569819263
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,20594,43,1.05 [0.83-1.32],0.7028952708655741
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,24596,47,9.91 [4.87-20.16],2.49658846716598e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,21262,44,1.48 [0.77-2.85],0.2440640814236155
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,20594,43,2.14 [1.35-3.37],0.0010965868721294
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,24348,49,1.35 [0.94-1.94],0.1015282963334988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,20648,42,1.11 [0.56-2.21],0.7591250800528073
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,24057,47,2.17 [1.43-3.29],0.0002764470606932
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,20648,42,0.90 [0.35-2.34],0.8274847402943913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,21262,44,1.17 [0.65-2.10],0.5939038910504202
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,20648,42,0.87 [0.54-1.43],0.5899418425839706
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,21224,44,0.88 [0.46-1.67],0.6886309827824648
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,21249,44,2.45 [1.07-5.60],0.033941852923662
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,20601,42,1.26 [0.74-2.14],0.4002026148904447
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,20594,43,1.18 [0.92-1.52],0.2007777127357063
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,18410,37,0.85 [0.61-1.18],0.3398074388903201
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,24519,48,5.22 [2.72-10.01],6.454489216104813e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,24061,48,1.48 [0.95-2.30],0.0841374181123824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,23884,48,0.72 [0.42-1.23],0.225458058976842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,24508,47,1.05 [0.81-1.35],0.7264484187346316
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,24158,49,2.04 [1.26-3.32],0.0037731976439407
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,20812,44,0.78 [0.43-1.43],0.4193157163681835
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,20968,44,1.03 [0.37-2.86],0.9500237143115078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,24072,47,0.79 [0.57-1.08],0.1446417905196854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,21249,44,4.53 [1.99-10.28],0.0003057683313483
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,21249,44,1.46 [0.75-2.85],0.2625207319092492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,20601,42,1.58 [0.90-2.78],0.1142543782443388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,24494,48,1.71 [1.13-2.58],0.010765984765374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,24477,47,1.15 [0.76-1.72],0.5105007315164338
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,21200,44,1.18 [0.77-1.80],0.453481899126391
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,24487,49,1.00 [0.62-1.63],0.9928380131492824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,24425,47,0.72 [0.39-1.33],0.2975148323120563
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,22834,43,1.14 [0.59-2.19],0.7041500798239013
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,20778,43,1.03 [0.60-1.75],0.9259441558231858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,24550,47,0.62 [0.33-1.14],0.1237601856249003
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,24004,46,0.89 [0.63-1.27],0.5352416331590737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,24515,49,1.75 [0.65-4.72],0.2711555262420269
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,24802,48,1.95 [0.90-4.22],0.0897025995471894
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,19360,40,1.93 [0.56-6.66],0.2999014626831354
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,24647,47,0.23 [0.13-0.40],5.788696122946587e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,24468,48,3.58 [1.74-7.37],0.0005215222111992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,20672,43,1.42 [0.81-2.50],0.2205534498348499
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,21048,44,1.22 [0.84-1.77],0.2915928583647701
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,24348,49,1.97 [1.02-3.81],0.044332712525515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,24494,49,1.74 [1.16-2.62],0.0072206862294061
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,24426,47,0.86 [0.65-1.14],0.2977755136537945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,24596,47,1.93 [1.53-2.42],1.8906222330920323e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,24739,49,1.23 [0.93-1.63],0.1504579071696019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,24057,47,1.03 [0.54-1.96],0.9200326511466234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,24739,49,1.62 [1.33-1.97],1.478508237142613e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,24057,47,0.95 [0.61-1.48],0.8154162406136515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,24747,49,3.64 [1.39-9.55],0.0085292493792119
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,24802,48,1.41 [0.87-2.30],0.1680308479620555
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,24473,47,0.82 [0.63-1.06],0.1249954010173866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,24430,49,0.91 [0.74-1.13],0.3855988394743171
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,24802,48,1.07 [0.77-1.49],0.6747256888021425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,24311,48,1.38 [1.03-1.84],0.0316226319770289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,24596,47,2.03 [1.59-2.58],1.0157584813368917e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,20501,41,0.97 [0.63-1.49],0.894494659829655
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,20911,44,1.24 [0.76-2.00],0.385371248692951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",20594,43,0.97 [0.69-1.37],0.8667455246677636
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,20501,41,0.61 [0.36-1.03],0.0627223322347216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,21249,44,2.36 [0.81-6.84],0.115002892725474
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,20778,43,0.96 [0.68-1.37],0.8389133410523937
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,24722,48,0.93 [0.75-1.16],0.5320656598917979
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,24596,47,0.67 [0.39-1.14],0.1404017660866411
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,20648,42,0.87 [0.51-1.51],0.6278717102411271
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,20648,42,0.95 [0.55-1.63],0.8399458159018516
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,24494,49,0.87 [0.72-1.06],0.1630116917915722
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",24301,49,0.88 [0.63-1.24],0.4768206158076823
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,21228,44,0.97 [0.76-1.24],0.8151369355023119
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,24378,48,0.87 [0.63-1.19],0.3811060190451655
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,20648,42,0.98 [0.55-1.74],0.9496434714627806
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,24596,47,0.88 [0.67-1.16],0.3604765831470812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",24550,47,1.31 [0.63-2.71],0.4715158680919519
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,20672,43,0.37 [0.08-1.80],0.2182979090200117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,20501,41,1.35 [0.97-1.89],0.0725494945269258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,20501,41,1.13 [0.45-2.85],0.7910227818581708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCN,Decorin,24072,47,1.74 [0.55-5.50],0.3463547196173514
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,20778,43,0.81 [0.60-1.09],0.1574265014292951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,24722,48,1.20 [0.82-1.75],0.3594512749639432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,24385,49,1.09 [0.84-1.42],0.5104623402910349
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,23928,49,0.81 [0.54-1.21],0.3060692129368598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,24515,49,1.76 [0.82-3.78],0.1467391172203515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,20601,42,1.08 [0.75-1.56],0.6842497504616692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,20501,41,1.02 [0.71-1.47],0.9095443177858722
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,24550,47,0.89 [0.57-1.40],0.6146728673608883
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,20594,43,0.71 [0.31-1.64],0.4237370987898899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",24385,49,1.71 [1.08-2.70],0.0224324159360063
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,24487,49,1.21 [0.74-2.00],0.4456180816026934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,21224,44,0.79 [0.51-1.22],0.2848755531359853
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,20778,43,1.02 [0.70-1.48],0.9156324097405684
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,24739,49,3.52 [1.71-7.25],0.0006498673294242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,21249,44,1.64 [0.90-2.99],0.1027385322362206
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,21165,44,0.57 [0.28-1.17],0.1251530509159099
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,20672,43,0.47 [0.17-1.29],0.1445308789154015
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,20648,42,0.84 [0.22-3.29],0.8078659174191561
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,20648,42,0.79 [0.42-1.50],0.4793746302923908
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,20672,43,1.52 [0.79-2.94],0.2092444140259873
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,23920,49,1.26 [0.88-1.79],0.2060130105791996
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",24494,49,0.88 [0.68-1.14],0.3391640361221343
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,23979,47,1.47 [0.99-2.18],0.0576080070172056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,20503,42,1.37 [0.80-2.35],0.2512948356501537
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,20601,42,0.69 [0.38-1.26],0.231239261248125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,20601,42,0.55 [0.30-1.01],0.0550106026015931
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,20601,42,0.54 [0.24-1.22],0.1374389926508986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,24127,49,1.11 [0.94-1.30],0.2112003782814547
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,20594,43,1.07 [0.62-1.85],0.8017369722080336
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,20648,42,0.49 [0.27-0.89],0.0201050237778649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,24802,48,0.73 [0.49-1.08],0.1121670945591691
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,20601,42,0.66 [0.28-1.51],0.3209782001331539
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,20648,42,0.74 [0.41-1.31],0.3005259578822199
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,24057,47,0.99 [0.48-2.03],0.968036617718669
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,20594,43,0.46 [0.21-1.02],0.0564795798012507
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,21141,44,1.50 [0.91-2.47],0.1092110716301066
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,21200,44,0.56 [0.27-1.16],0.1187366987753981
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",24425,49,0.87 [0.69-1.09],0.2159823377846385
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,20672,43,0.47 [0.20-1.11],0.0854905920315848
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,20778,43,0.98 [0.36-2.71],0.9740188131617408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,24739,49,0.90 [0.60-1.36],0.6221123253319634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,24797,49,1.70 [0.73-3.98],0.2175519914764938
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,24305,49,0.97 [0.57-1.68],0.92701215149884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,24385,49,1.12 [0.82-1.52],0.4673016798631061
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,21200,44,0.91 [0.60-1.37],0.6417449849878554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,21224,44,0.96 [0.55-1.70],0.8981096846826053
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,24797,49,1.72 [1.11-2.68],0.0152932619553213
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,24550,47,5.10 [2.40-10.85],2.272336598577435e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,20668,42,0.71 [0.39-1.31],0.2725873073616555
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,20668,42,1.46 [0.93-2.28],0.1000026518359694
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,20668,42,1.53 [0.89-2.62],0.1213857816183354
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,20501,41,1.11 [0.63-1.97],0.7198292521846583
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,24714,48,0.96 [0.71-1.31],0.8095040586847716
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,21200,44,1.35 [0.93-1.96],0.1184037118467478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,24385,49,0.81 [0.61-1.08],0.1581234944094401
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,21165,44,0.82 [0.52-1.29],0.3913939048629286
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,20778,43,0.76 [0.44-1.33],0.33790649925896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,20580,43,0.81 [0.57-1.15],0.2399905787538125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,24072,47,0.69 [0.39-1.21],0.1924785513500994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,21200,44,2.06 [1.24-3.44],0.0055676721546708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,20668,42,0.99 [0.70-1.40],0.9528124825672568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,21165,44,1.07 [0.75-1.55],0.6996683433354072
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,24440,47,1.02 [0.39-2.67],0.9729605901093574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,20601,42,0.93 [0.64-1.33],0.6827946907593203
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,21165,44,0.84 [0.66-1.07],0.154430141007907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,21224,44,0.94 [0.55-1.61],0.8236376285472103
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,24348,49,0.95 [0.63-1.43],0.8106656004053054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,21200,44,1.63 [1.02-2.62],0.0423899128292282
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,24545,47,0.93 [0.57-1.52],0.7662137814775549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,20672,43,0.73 [0.28-1.91],0.5248598849976704
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,20601,42,0.96 [0.73-1.26],0.7499001350651716
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,21200,44,0.88 [0.72-1.08],0.229105765110357
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,24515,49,0.91 [0.74-1.11],0.3448778849616404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,24301,49,0.72 [0.44-1.16],0.1767170734095462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,24385,49,1.19 [0.51-2.78],0.6940233561065093
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,24494,49,1.63 [0.88-3.04],0.1212552191858185
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,23991,47,2.13 [0.94-4.82],0.0699830784359997
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,24385,49,0.83 [0.39-1.73],0.61248502594608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,24310,48,1.05 [0.70-1.59],0.8061099392646768
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,24797,49,4.45 [1.63-12.15],0.0036229674365828
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,24657,48,1.35 [0.94-1.93],0.1000414504834373
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,24348,49,2.50 [1.44-4.32],0.0010580501513366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,24385,49,0.84 [0.53-1.32],0.4429450871552303
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,24196,47,3.65 [2.00-6.66],2.4352514778901384e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,21224,44,1.33 [0.60-2.94],0.4767481184295502
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,24494,48,1.09 [0.43-2.74],0.854200276335815
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,24651,48,1.61 [0.81-3.22],0.1768974298843317
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,24295,49,0.56 [0.35-0.91],0.018683491374795
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,20778,43,0.87 [0.62-1.21],0.4099619531634092
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,21105,44,1.87 [1.17-2.97],0.0083571204319711
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,20672,43,0.59 [0.32-1.09],0.0932436297898637
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,24385,49,4.03 [2.08-7.80],3.541080898479517e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,21257,44,0.95 [0.63-1.44],0.8229795152813115
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,24072,47,0.72 [0.45-1.14],0.1555815917884099
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,21141,44,1.42 [0.78-2.60],0.2479337641724637
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,20672,43,1.18 [0.82-1.69],0.3682803074337935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,23928,49,0.87 [0.62-1.21],0.3997806602929475
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",21165,44,0.97 [0.73-1.28],0.8112834580422226
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,21200,44,1.12 [0.60-2.08],0.7195877922636459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,21141,44,1.01 [0.55-1.84],0.981978355233083
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,20672,43,0.83 [0.55-1.24],0.3600845545668482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,21141,44,0.81 [0.41-1.60],0.5511934281884117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,24348,49,0.92 [0.70-1.20],0.5175778815441976
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,24690,48,2.87 [1.73-4.78],4.7190389840205135e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,23928,49,0.81 [0.39-1.66],0.5579102046160115
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",21257,44,1.07 [0.74-1.53],0.729277399443618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",20668,42,0.96 [0.71-1.29],0.7694309956195209
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,20594,43,0.88 [0.54-1.45],0.6260994728617266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,20682,43,0.61 [0.31-1.23],0.1697067252922137
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,20601,42,1.17 [0.71-1.94],0.5305416546163036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,24722,48,4.21 [2.53-7.00],3.024168328871895e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,24494,49,0.60 [0.45-0.80],0.0005037344196561
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,21141,44,0.92 [0.65-1.29],0.6147287083636271
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,20594,43,0.70 [0.27-1.80],0.4608578671838187
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,21224,44,0.80 [0.50-1.28],0.3481551667978112
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,24072,47,1.64 [0.89-3.03],0.1126548853299103
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,20668,42,2.01 [0.78-5.16],0.1484250474769322
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,20648,42,0.94 [0.47-1.85],0.8496195033504718
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,21257,44,0.95 [0.70-1.31],0.7703943988639188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,21165,44,2.27 [1.30-3.96],0.0040816859852553
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,20858,44,0.26 [0.10-0.68],0.0057722629754393
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,24511,48,3.39 [1.66-6.92],0.0008132494970647
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,21224,44,1.89 [1.07-3.32],0.0270670038650248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,24450,48,4.88 [2.47-9.62],4.880387452621003e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,24307,49,4.40 [2.41-8.04],1.4739879333768504e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,20672,43,1.26 [0.88-1.80],0.2110007605563081
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,24435,47,0.83 [0.65-1.05],0.1213281627732932
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,23920,49,1.34 [0.75-2.40],0.3279901918988703
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,21165,44,0.73 [0.28-1.92],0.5194819231159231
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,24797,49,1.24 [0.26-5.77],0.7881798015120258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,24494,49,1.01 [0.64-1.58],0.9710144138016312
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,21257,44,0.87 [0.59-1.28],0.4825040558355692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,20668,42,0.82 [0.64-1.04],0.1067621374957153
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",21200,44,0.96 [0.56-1.65],0.8961662747143752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",21103,44,0.96 [0.73-1.25],0.7396858363619712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,20594,43,0.84 [0.52-1.35],0.474078177204408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,20668,42,1.10 [0.56-2.16],0.7917058846037495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,24348,49,0.89 [0.58-1.36],0.5762662081108645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,20648,42,0.90 [0.65-1.25],0.5379734446687557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,24515,49,1.06 [0.73-1.54],0.7683365958936051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,24802,48,1.03 [0.80-1.32],0.8302023520855522
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,21224,44,0.76 [0.47-1.21],0.2438664176381553
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,20594,43,0.93 [0.47-1.84],0.8360017504218445
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,24057,47,1.34 [0.64-2.83],0.4354163931268728
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,21224,44,0.84 [0.61-1.17],0.3129378607184965
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,20601,42,0.91 [0.63-1.32],0.6199930884975403
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELN,Elastin,21257,44,2.43 [1.12-5.24],0.0238395858132234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,24385,49,1.18 [0.80-1.74],0.4057794968746647
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,20594,43,0.68 [0.29-1.59],0.3693857811135703
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,24057,47,1.79 [1.15-2.79],0.0096971965957068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,19645,41,0.76 [0.44-1.32],0.3289268793116364
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,24797,49,2.45 [0.58-10.40],0.223755119995255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,24484,49,0.84 [0.61-1.14],0.2634640370607949
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,24739,49,0.81 [0.55-1.19],0.2897147028059609
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,20668,42,0.70 [0.42-1.18],0.1803302747370793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,21141,44,0.66 [0.38-1.13],0.1281783630019511
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,20594,43,1.00 [0.35-2.87],0.998579542726743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,20594,43,0.57 [0.22-1.46],0.2388652910192211
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,24797,49,1.03 [0.48-2.22],0.9430443119717128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,24596,47,0.76 [0.48-1.21],0.2538729691569819
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,20668,42,0.82 [0.37-1.82],0.6281840584337264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,23779,44,1.14 [0.84-1.55],0.3866345604145285
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,21141,44,0.47 [0.25-0.87],0.0167844188427975
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,23920,49,1.72 [1.02-2.90],0.0415890090174989
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,24072,47,1.13 [0.34-3.78],0.8392507995949087
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,24072,47,3.78 [1.23-11.64],0.020612541346841
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,20668,42,1.07 [0.67-1.73],0.7720861643600804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,20648,42,1.19 [0.48-2.93],0.710708172171973
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,20672,43,1.02 [0.66-1.58],0.9298483373641608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,24480,47,1.09 [0.84-1.42],0.5153493864064832
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,21141,44,0.27 [0.08-0.92],0.0367498485926158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,24545,47,2.35 [1.13-4.91],0.0223808765559523
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,23928,49,0.90 [0.58-1.39],0.6253127464409654
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,23627,46,4.71 [2.73-8.15],2.8763375263701134e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,20778,43,1.16 [0.41-3.24],0.7796213359011359
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,24797,49,5.27 [2.67-10.40],1.6660794466757152e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,24301,49,3.61 [1.71-7.64],0.000781465211373
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,24072,47,1.10 [0.75-1.62],0.6215586498658806
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,20858,44,1.10 [0.59-2.06],0.7642586265824227
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,24494,49,1.49 [1.22-1.82],0.0001000202277425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,20668,42,0.63 [0.42-0.95],0.0286942040525482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,24689,48,2.35 [1.20-4.61],0.013043456104513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,24550,47,2.30 [0.89-5.97],0.0867262694056905
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,24381,47,1.79 [0.51-6.29],0.3630357760905776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,24550,47,0.77 [0.27-2.20],0.6289793750894404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,24385,49,0.91 [0.71-1.15],0.4283139174449767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,20672,43,0.62 [0.36-1.08],0.0890477361027824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,20501,41,1.05 [0.42-2.60],0.9191591253963994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,24301,49,0.73 [0.52-1.03],0.0760133677020057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,20858,44,1.63 [0.82-3.25],0.160721099588185
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,20648,42,0.84 [0.44-1.61],0.606216010448005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,21141,44,1.13 [0.55-2.34],0.733200636618175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,20778,43,0.89 [0.70-1.13],0.3433963095285675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,24351,49,0.62 [0.23-1.64],0.3366392877930639
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,20594,43,0.61 [0.28-1.31],0.2035259945456459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,24797,49,1.69 [0.81-3.55],0.1634424308091281
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,24476,47,1.22 [0.58-2.54],0.5977363201191161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,20501,41,0.87 [0.47-1.63],0.6664085399595102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,20648,42,0.99 [0.60-1.66],0.9787753405582108
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,21200,44,0.89 [0.62-1.27],0.5173844517978443
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,20501,41,0.65 [0.25-1.68],0.3744175639629682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,20648,42,0.87 [0.62-1.21],0.4141314722338555
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,20858,44,0.95 [0.39-2.33],0.9172164535214506
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,20594,43,1.23 [0.83-1.81],0.3092067883082174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,20594,43,1.05 [0.58-1.89],0.8706175583843767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,24739,49,4.14 [1.81-9.51],0.0007878192894779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,21262,44,1.44 [0.58-3.56],0.4314767088535209
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,20973,43,1.08 [0.48-2.41],0.8498838579877633
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,24494,48,0.82 [0.52-1.30],0.4030540160030901
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,21282,44,1.04 [0.53-2.05],0.9061475827696602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,21172,44,1.20 [0.40-3.64],0.7463482831879561
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,21282,44,1.43 [0.21-9.88],0.715959160103248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,24561,47,0.72 [0.46-1.13],0.1518301934101666
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,24566,48,5.69 [2.56-12.62],1.961583118055422e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,24520,48,2.27 [0.98-5.25],0.0549985105238204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,24531,48,4.28 [1.13-16.30],0.0329347894440111
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",24476,47,1.30 [1.02-1.66],0.0339740127843357
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",24515,49,1.48 [1.11-1.97],0.0077729082451207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",21257,44,1.86 [1.24-2.77],0.0024580320484846
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",24797,49,2.15 [1.42-3.24],0.0002697284674891
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,24672,49,1.02 [0.71-1.46],0.9108299857760742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,24039,47,1.07 [0.67-1.70],0.7875267574756254
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,24494,49,0.89 [0.57-1.41],0.6247638706605287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,24515,49,0.82 [0.59-1.14],0.2446522317026054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,21165,44,1.11 [0.73-1.67],0.6286500367043644
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,21224,44,0.70 [0.54-0.90],0.005760291587171
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,21141,44,0.78 [0.25-2.44],0.6714681072213882
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,20668,42,0.60 [0.37-1.00],0.0481733404254394
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,21257,44,2.04 [0.79-5.27],0.1406891906943604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,24385,49,1.59 [0.79-3.22],0.1948257867658944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,24487,49,3.49 [1.63-7.49],0.0013249978871184
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,21165,44,1.36 [0.97-1.91],0.0706840770200956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,24797,49,2.58 [1.06-6.31],0.0374145830695948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,20672,43,0.70 [0.42-1.15],0.160188700782805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,24707,49,1.74 [1.15-2.62],0.0083637247093163
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,24802,48,1.61 [0.83-3.13],0.1613551715056675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,21249,44,2.85 [1.22-6.64],0.0152197008991491
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,20672,43,0.73 [0.46-1.15],0.175031772510828
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",24515,49,1.15 [0.82-1.59],0.4202038770505046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,21257,44,1.46 [1.01-2.10],0.042924760335991
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,24494,49,0.91 [0.53-1.56],0.7377825707828525
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,21224,44,1.55 [0.50-4.76],0.4440251650536682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,24494,48,1.62 [0.98-2.69],0.0601876753094593
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,24366,48,1.34 [0.81-2.24],0.258352377142021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,23920,49,1.07 [0.70-1.63],0.7634634223379931
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,24480,48,0.79 [0.49-1.28],0.3411103975175383
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,21228,44,0.75 [0.50-1.13],0.1727144982826418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,24362,48,1.65 [0.84-3.23],0.1465078410635149
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,24515,49,1.15 [0.65-2.03],0.6392566317552291
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,24695,48,0.25 [0.15-0.42],2.3703524678355137e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,24057,47,0.67 [0.41-1.10],0.1147969075528929
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,24494,48,0.26 [0.17-0.41],2.2328565098321754e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,24494,49,1.20 [0.82-1.75],0.3466288295450015
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,23920,49,1.41 [0.99-1.99],0.0539867100390012
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",20594,43,1.03 [0.65-1.61],0.9078863131265442
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",20594,43,1.66 [1.22-2.27],0.0013153770069274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,23920,49,0.77 [0.48-1.24],0.2810900009211823
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,23920,49,1.48 [0.98-2.25],0.0622095752170508
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,24531,48,1.65 [0.77-3.53],0.1959940056437645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,20785,42,3.12 [1.42-6.85],0.0045755902246282
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",21224,44,0.81 [0.56-1.16],0.2448599955538717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,20648,42,1.09 [0.61-1.95],0.7752315860160013
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,20648,42,0.85 [0.43-1.69],0.6460368571668277
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,24596,47,0.97 [0.70-1.35],0.855838091782373
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,24494,49,1.23 [0.86-1.76],0.2515615190124889
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,20648,42,0.57 [0.22-1.42],0.2259436643904288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,24690,48,1.08 [0.89-1.31],0.4583039517106366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,24684,48,1.24 [0.89-1.71],0.2024534387560081
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,20648,42,0.36 [0.10-1.31],0.1216958573313178
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,24057,47,0.99 [0.46-2.14],0.9761438614848956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,20648,42,0.73 [0.30-1.76],0.4879719362061341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,20501,41,1.24 [0.93-1.64],0.1392276888917932
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,20458,41,0.71 [0.34-1.48],0.3625043355003691
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,24550,47,1.24 [0.57-2.72],0.5895527309522934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,21249,44,0.91 [0.52-1.61],0.7567020454941956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,21200,44,2.13 [1.01-4.51],0.046860331879837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,24550,47,6.08 [2.71-13.64],1.1899120625896876e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,20778,43,0.96 [0.56-1.64],0.8760779513350365
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,21262,44,1.64 [1.09-2.48],0.0172071184040698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,23928,49,0.73 [0.43-1.22],0.2243431591032119
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",20601,42,1.06 [0.76-1.48],0.7112865057864974
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,20594,43,1.03 [0.57-1.86],0.9125986998287128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,23928,49,0.73 [0.52-1.02],0.067533103862411
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,24457,47,0.84 [0.60-1.17],0.2974587952420139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,21224,44,0.80 [0.60-1.06],0.1237281207921281
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,24605,48,0.91 [0.73-1.15],0.4371264309108824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,24348,49,0.96 [0.55-1.69],0.8825060967833422
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,24348,49,0.84 [0.65-1.09],0.1997948556080956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,23881,49,0.74 [0.39-1.37],0.3350015234483767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,21165,44,0.95 [0.59-1.54],0.835017036469035
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,23920,49,0.84 [0.66-1.07],0.1559365102484801
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,24348,49,1.43 [0.61-3.40],0.412048871818408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,24344,49,1.40 [0.55-3.55],0.4795572394576147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,23920,49,0.40 [0.16-1.01],0.0513086917725377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,24802,48,,
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,24550,47,1.46 [0.68-3.15],0.3338941423725868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,23928,49,1.04 [0.73-1.50],0.8171419624362126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,23920,49,1.06 [0.51-2.17],0.8789490509548636
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,21282,44,0.51 [0.17-1.50],0.2200478791068055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,21200,44,1.16 [0.62-2.15],0.641084552488552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,21141,44,0.71 [0.29-1.70],0.4356503734864587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,20648,42,1.00 [0.76-1.31],0.9839621982147788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,24431,47,4.07 [2.05-8.05],5.700902276741976e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,24739,49,3.57 [1.75-7.28],0.0004648465919477
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,24473,47,1.03 [0.91-1.17],0.6185237631027936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,20458,41,0.97 [0.42-2.23],0.9369189340456336
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,23928,49,1.32 [0.82-2.13],0.2557894529976999
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,20648,42,0.82 [0.41-1.65],0.5820311703458121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,24494,49,0.82 [0.61-1.10],0.1929723330338959
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,23920,49,0.86 [0.65-1.13],0.2731077151190153
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,20594,43,0.91 [0.59-1.40],0.6634629943555423
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,20672,43,0.64 [0.27-1.51],0.3070690131473405
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,24272,49,1.09 [0.45-2.68],0.8455217761908006
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,20668,42,1.65 [1.19-2.30],0.0030276466455678
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FST,Follistatin,24561,47,0.99 [0.60-1.62],0.9574054358643568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,20668,42,2.23 [0.66-7.55],0.197216073061381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,24441,47,5.02 [2.87-8.75],1.3822305868358788e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,21164,44,1.04 [0.75-1.44],0.8339298651197582
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,24627,48,0.73 [0.56-0.96],0.0222279116009527
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,20778,43,1.20 [0.78-1.86],0.4100049969432886
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FURIN,Furin,24550,47,1.76 [0.84-3.70],0.1334636131339274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,23882,49,1.15 [0.63-2.11],0.6530428050826749
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",20823,44,0.68 [0.39-1.20],0.1836453157935152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,24739,49,1.68 [0.98-2.89],0.0602899475500015
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",24348,49,0.68 [0.43-1.07],0.091719681549437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",24722,48,0.86 [0.61-1.21],0.3867709594644167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,24057,47,0.84 [0.55-1.27],0.3996274909528167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,24456,48,0.76 [0.58-1.00],0.0496941540712925
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,20672,43,0.49 [0.24-1.01],0.0521738154169887
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,20601,42,1.05 [0.53-2.09],0.8891286882186854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,21141,44,1.08 [0.61-1.91],0.7802895844080022
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,20858,44,1.17 [0.80-1.70],0.4146592552196617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,20601,42,0.65 [0.35-1.20],0.1707055960676795
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,20501,41,1.52 [0.49-4.68],0.4668617949026474
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,20648,42,1.06 [0.57-1.98],0.8586005508160173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,20858,44,0.78 [0.37-1.63],0.5042623911133867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,20668,42,0.80 [0.44-1.43],0.4450128125873219
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,20501,41,1.04 [0.65-1.66],0.8720429556860105
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,24596,47,0.66 [0.44-0.97],0.0356916538470542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,24385,49,1.18 [0.49-2.82],0.7146733975468145
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,24722,48,1.01 [0.39-2.66],0.9771060379612004
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,24057,47,2.11 [1.22-3.67],0.007764731302239
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,21257,44,1.10 [0.39-3.08],0.8585575675916404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,24385,49,1.78 [0.53-6.06],0.3534730880211373
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,20594,43,0.88 [0.37-2.12],0.7766176251256166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,20335,43,0.97 [0.40-2.34],0.9535969037951312
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,21224,44,1.52 [0.70-3.29],0.2867497352114893
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,20858,44,0.88 [0.48-1.62],0.6851399343830158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,24620,49,1.85 [0.72-4.74],0.1975858805797546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,20594,43,1.58 [0.82-3.05],0.1738722121739856
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,21200,44,1.14 [0.92-1.41],0.2287460947998251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,20501,41,2.16 [0.74-6.33],0.1594466037034496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",20668,42,0.79 [0.53-1.17],0.2431051734255983
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,20672,43,0.74 [0.43-1.28],0.2846346782660733
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,21161,44,1.91 [1.38-2.64],9.6484171333819e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,24057,47,0.86 [0.56-1.34],0.5134397291890754
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,23928,49,0.83 [0.48-1.44],0.5107393374650944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,20594,43,0.77 [0.35-1.66],0.4986785604824162
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,21282,44,0.87 [0.29-2.65],0.8060857166456405
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,21200,44,0.83 [0.64-1.08],0.1658103135830783
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,23920,49,1.10 [0.90-1.34],0.3635238076490512
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,20267,42,1.30 [0.82-2.07],0.2642506316532286
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,20594,43,1.13 [0.63-2.02],0.6796510189113383
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",24385,49,3.37 [1.79-6.33],0.0001663593901275
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,24797,49,1.76 [1.29-2.40],0.0004046355561823
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,24515,49,0.77 [0.39-1.50],0.4384564315037687
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,23928,49,1.57 [0.88-2.83],0.1293462429987179
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,21257,44,1.01 [0.61-1.67],0.9761999838336988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,23886,49,1.39 [0.80-2.40],0.246495213217223
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,23920,49,1.07 [0.73-1.57],0.7363235377218185
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,23920,49,0.84 [0.64-1.10],0.198886132713507
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,24690,48,,
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,24385,49,3.59 [1.41-9.10],0.0072111456104547
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,24266,48,1.81 [0.76-4.34],0.1802307871279802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,20594,44,0.90 [0.56-1.44],0.6522499724907824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,23928,49,0.45 [0.26-0.78],0.004354848892509
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,21257,44,0.84 [0.56-1.26],0.4067146759079395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,21220,44,0.70 [0.38-1.30],0.262909379450429
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,24042,47,2.03 [1.14-3.60],0.0155566839271337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,24450,48,1.09 [0.69-1.74],0.7026074658135719
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,24348,49,2.65 [1.07-6.55],0.034513522602546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,24487,49,1.08 [0.95-1.22],0.2471479501185356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,23920,49,0.81 [0.66-0.99],0.0404359382976139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,20778,43,2.36 [0.86-6.48],0.096516770774023
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,23928,49,1.26 [0.89-1.77],0.1918525834407713
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,24515,49,0.96 [0.70-1.31],0.7989101132622745
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,21224,44,0.67 [0.23-1.94],0.4630848840154501
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,21224,44,1.38 [0.98-1.94],0.0622071134158113
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,20778,43,1.23 [0.55-2.73],0.6132268541163242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,20501,41,1.33 [0.81-2.20],0.264091595238359
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,20668,42,0.88 [0.45-1.75],0.7217481231347435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,21200,44,3.76 [1.93-7.31],9.534444874890194e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,21165,44,0.90 [0.68-1.19],0.4503741138680036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,20648,42,0.50 [0.22-1.14],0.1001502835901145
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,20648,42,0.91 [0.67-1.24],0.557640837673794
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,20501,41,0.88 [0.52-1.51],0.642920851661658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,23464,49,1.79 [0.75-4.27],0.1888877161776105
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,20732,43,1.10 [0.52-2.34],0.8015821944429875
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,24348,49,0.86 [0.48-1.55],0.618811912085091
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,20648,42,1.32 [0.64-2.70],0.4494358059144981
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,24072,47,1.05 [0.68-1.63],0.8188946932871862
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,24422,47,0.78 [0.39-1.57],0.4809772485117564
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,20601,42,0.56 [0.21-1.49],0.2470100344267797
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,24362,48,1.15 [0.75-1.77],0.5162796327565885
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",20778,43,0.94 [0.68-1.31],0.7150235453409552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,23928,49,0.50 [0.23-1.06],0.0697571945682504
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,21141,44,0.53 [0.27-1.05],0.0674693244146063
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,20745,42,1.68 [1.15-2.45],0.0076973859818097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,21257,44,0.78 [0.53-1.16],0.2245714144745633
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,24802,48,1.06 [0.65-1.73],0.8212874411407374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,20778,43,0.90 [0.58-1.40],0.6362011661765767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,21224,44,0.98 [0.71-1.35],0.8882057098413016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,23920,49,0.79 [0.53-1.19],0.2543746743690339
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,20672,43,0.67 [0.32-1.40],0.2863157725000683
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,24494,48,1.96 [1.25-3.07],0.0034686236281985
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,20668,42,1.01 [0.42-2.41],0.9856300025466312
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,20778,43,0.70 [0.31-1.56],0.3796671228377496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,21224,44,0.87 [0.59-1.29],0.496056251921477
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,24739,49,2.23 [0.81-6.15],0.1228755611103872
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,24494,49,0.80 [0.63-1.02],0.0772478975509987
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,21165,44,0.96 [0.52-1.77],0.9063029152637788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",21249,44,0.94 [0.49-1.83],0.8628122490518946
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,24370,48,0.79 [0.36-1.74],0.5622573660713859
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,20594,43,0.97 [0.63-1.49],0.8821845950238374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,23758,47,0.99 [0.73-1.34],0.9257466897157314
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,20778,43,0.37 [0.19-0.74],0.0047323345886333
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,24456,48,0.78 [0.59-1.03],0.0797946833561619
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,24385,49,1.04 [0.86-1.25],0.7026777143638172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,24722,48,3.21 [1.40-7.35],0.0058412010834879
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,24348,49,0.58 [0.37-0.90],0.0151452618364119
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,21141,44,1.52 [0.94-2.46],0.0907087743795384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,21165,44,0.64 [0.28-1.43],0.2729974503145321
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,21262,44,0.82 [0.44-1.51],0.5266722264103052
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,21165,44,1.40 [0.89-2.20],0.1441704550085515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,23928,49,1.45 [0.75-2.81],0.2704210407786066
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,23858,48,2.62 [1.09-6.34],0.0320980456315284
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,20601,42,1.24 [0.88-1.76],0.2172207058552578
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,21224,44,0.69 [0.27-1.74],0.4272015595194846
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,21165,44,1.35 [0.89-2.05],0.1571338138611039
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,24072,47,1.29 [0.88-1.91],0.1946042710919153
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,21141,44,1.11 [0.69-1.77],0.6721944951476222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,24515,49,0.87 [0.72-1.05],0.1440493153724104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,21257,44,0.90 [0.58-1.40],0.6400562418335523
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",21224,44,0.72 [0.31-1.64],0.4340230124290732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",20601,42,0.73 [0.37-1.45],0.3680947607106001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,24072,47,0.59 [0.31-1.11],0.1036223137280236
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,24375,48,2.00 [0.77-5.21],0.1538095417149358
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,20668,42,1.21 [0.69-2.12],0.5162544039784394
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",24385,49,1.08 [0.73-1.60],0.6967671083218859
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,20384,41,0.88 [0.60-1.30],0.527919603102537
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,23920,49,0.82 [0.56-1.18],0.2847752064656107
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,21176,44,0.42 [0.10-1.72],0.2273611179750814
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",21141,44,2.60 [0.79-8.56],0.1159875585622483
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,24479,48,1.01 [0.76-1.35],0.9374152521769956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,23920,49,1.16 [0.85-1.58],0.3594962903107245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,20594,43,1.14 [0.80-1.63],0.4644388189868632
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,23775,49,0.90 [0.62-1.32],0.5966258549143973
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,21200,44,0.92 [0.82-1.04],0.1935580238710904
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,20858,44,1.12 [0.80-1.57],0.5121626771472769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,20672,43,0.79 [0.55-1.15],0.2271791664097303
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,24375,48,2.45 [1.19-5.05],0.0151916512181771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,20858,44,0.67 [0.41-1.08],0.1012789411409257
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,20594,43,1.23 [0.71-2.12],0.4610994829866541
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,24585,48,1.27 [0.85-1.87],0.2398041374551952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",24072,47,0.83 [0.63-1.11],0.2050710028973578
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,24802,48,2.33 [1.29-4.21],0.0048747795523023
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,24494,49,1.01 [0.69-1.46],0.9674241638662556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,24072,47,1.30 [1.03-1.66],0.0300644190435693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,20501,41,1.05 [0.58-1.89],0.8793642378355355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",20594,43,0.64 [0.33-1.25],0.1909333790403631
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",24659,48,1.22 [0.88-1.69],0.2428578519950109
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,24722,48,1.05 [0.87-1.26],0.6226116657957859
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",24494,48,0.89 [0.64-1.23],0.4672015900913507
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,24691,48,2.21 [1.62-3.00],4.304610643918365e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,24494,48,3.94 [2.34-6.62],2.355796172035273e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,24659,48,0.60 [0.42-0.85],0.0036921572257691
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,24722,48,0.89 [0.59-1.35],0.586620808222738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,21257,44,0.89 [0.68-1.17],0.4098666118557096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,20594,43,1.00 [0.58-1.70],0.99014727603776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,24802,48,0.79 [0.50-1.23],0.2873391073641749
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,20648,42,0.92 [0.54-1.55],0.7463452028927722
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,20601,42,1.16 [0.79-1.71],0.4501881895534549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,21165,44,0.79 [0.41-1.54],0.4907248726584449
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,24692,48,1.18 [0.91-1.54],0.2127630023549971
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,21200,44,0.78 [0.49-1.26],0.3151063694833399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,24072,47,0.83 [0.49-1.40],0.4737093626157205
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,20778,43,2.16 [0.79-5.90],0.1313207144146517
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,21200,44,2.40 [1.25-4.60],0.0084067229730406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,21257,44,1.24 [0.41-3.73],0.6984024567397662
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,24494,49,0.89 [0.65-1.22],0.4753901353562891
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,24802,48,1.37 [0.68-2.75],0.377999296830839
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,21065,44,0.98 [0.36-2.69],0.9685032820154784
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,23920,49,0.85 [0.60-1.19],0.3321365485404267
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,21200,44,0.89 [0.62-1.30],0.5569580656304111
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,20648,42,1.28 [0.96-1.71],0.0927832809561272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,20594,43,1.04 [0.45-2.42],0.927005594840024
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,21166,44,1.57 [1.12-2.21],0.0090214910672519
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,21224,44,1.37 [0.81-2.32],0.2436246536676872
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,24072,47,1.41 [0.58-3.44],0.446932605262713
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",21224,44,1.94 [0.78-4.81],0.151978780190066
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",24411,49,1.47 [0.75-2.88],0.2616583691871764
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",24494,49,4.25 [2.26-7.98],6.814190292699244e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,24722,48,1.31 [0.74-2.30],0.3552578233217542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,20736,43,1.01 [0.61-1.67],0.9792132137640048
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",20668,42,0.64 [0.34-1.23],0.1829144080513859
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",20594,43,1.39 [0.83-2.32],0.2045228460921043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,20465,41,0.85 [0.42-1.70],0.642133690989825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,24240,49,2.05 [1.32-3.18],0.0013637075044388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,23928,49,0.99 [0.58-1.68],0.9562245914621268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,20672,43,0.80 [0.48-1.34],0.3913914753349254
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,24226,49,1.83 [1.13-2.97],0.0146634800464108
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,23986,47,0.89 [0.64-1.25],0.5089885859726493
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,21224,44,0.91 [0.50-1.66],0.767941026273418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,24802,48,0.87 [0.62-1.21],0.3998214640833296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,23920,49,1.34 [0.71-2.53],0.3599951296305824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,20969,43,0.98 [0.73-1.34],0.9213844204110512
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,20829,44,1.00 [0.74-1.34],0.9928792228544016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,20668,42,1.44 [0.71-2.90],0.3100066823390786
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,21172,44,0.51 [0.21-1.20],0.123593743603462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,20668,42,0.78 [0.56-1.09],0.1409529507580056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,24385,49,1.11 [0.58-2.16],0.7490766634813779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,24722,48,1.21 [0.60-2.46],0.5951900076039043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,20648,42,1.09 [0.47-2.53],0.8485377683126197
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,20668,42,0.91 [0.67-1.24],0.5544687039686615
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,24494,49,0.70 [0.37-1.32],0.2737643835958195
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,21200,44,1.50 [0.97-2.31],0.0662714993076892
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,20594,43,1.41 [0.87-2.29],0.1617521117011612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,20668,42,1.10 [0.60-2.00],0.7645000052972079
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,23824,49,0.84 [0.54-1.32],0.4551738081175461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,24545,47,0.86 [0.60-1.24],0.4121472975833954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,21141,44,1.80 [1.08-2.99],0.0237253062010193
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,24097,48,1.00 [0.70-1.44],0.989367191212414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,24722,48,2.44 [1.49-4.01],0.0003944374198317
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,24285,48,3.76 [2.06-6.87],1.6441899785675635e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,20601,42,1.09 [0.77-1.53],0.6420659244694966
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,20601,42,1.40 [0.78-2.50],0.2578310946712711
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",24550,47,0.94 [0.62-1.42],0.7615362296831927
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,24322,47,0.92 [0.30-2.81],0.8885355587304283
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,24797,49,,
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,24057,47,0.76 [0.54-1.07],0.1115380654194983
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,24370,48,5.44 [2.99-9.90],2.856228857974625e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,24797,49,0.81 [0.37-1.81],0.6137680542774491
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,24797,49,0.46 [0.17-1.25],0.1262691097964427
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,24494,49,0.83 [0.52-1.32],0.4257241914006778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,24515,49,0.96 [0.56-1.67],0.8975312246922529
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,24385,49,3.22 [0.87-11.89],0.0799697927442184
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,20858,44,0.46 [0.17-1.19],0.1097002140752504
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,23928,49,1.04 [0.61-1.77],0.8797304248173674
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",20668,42,1.28 [0.85-1.94],0.235472854984011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,24802,48,2.81 [0.25-31.75],0.4026254429055668
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,24722,48,1.17 [0.68-2.03],0.5661733289040665
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,20687,44,2.36 [1.34-4.15],0.0030535239269517
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,20858,44,1.02 [0.58-1.77],0.9488929051293724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,20858,44,1.79 [0.99-3.24],0.0527865098210762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,21165,44,0.78 [0.25-2.40],0.6653215862423809
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,24057,47,1.49 [1.24-1.78],2.1547238247517664e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,24596,47,5.36 [2.52-11.39],1.2629221043332212e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,24348,49,1.29 [0.82-2.04],0.2674921154413744
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,23928,49,1.97 [1.35-2.87],0.0004418253910643
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,20601,42,0.80 [0.46-1.42],0.4546951132887044
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,24494,49,1.71 [1.07-2.72],0.0252285519954497
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,20594,43,0.91 [0.38-2.17],0.8277639112993951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,20672,43,0.74 [0.36-1.53],0.4163050818525413
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,21224,44,0.93 [0.58-1.48],0.7544759904406275
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,20601,42,1.23 [0.76-2.00],0.4036981917047184
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,21249,44,0.95 [0.32-2.83],0.9326354213539642
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,24385,49,2.43 [1.39-4.26],0.0018943624325547
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,20594,43,0.88 [0.44-1.76],0.7255917997577858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,24494,48,4.09 [1.49-11.18],0.0061150960631092
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,24755,49,0.92 [0.75-1.12],0.3977200214247748
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,24750,49,1.40 [0.94-2.10],0.1018267786332573
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,24560,48,3.71 [1.40-9.80],0.0082021862361307
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,24174,48,2.73 [1.84-4.06],7.006440408672847e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,24371,48,2.30 [1.19-4.44],0.0133774806216995
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,24797,49,1.77 [0.91-3.44],0.0943235490356917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,24515,49,1.93 [0.98-3.80],0.0581611728370251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,20648,42,0.91 [0.58-1.41],0.6657981335503107
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,20594,43,0.71 [0.39-1.29],0.2566898076911238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,21251,44,0.13 [0.02-0.80],0.02759953007342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,20501,41,0.81 [0.52-1.26],0.349815229283874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,20668,42,0.79 [0.37-1.68],0.5358613357955309
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,24385,49,2.03 [1.33-3.08],0.0009321878287708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,24515,49,1.10 [0.49-2.51],0.8132119357067342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,21257,44,1.08 [0.77-1.51],0.6495558747017001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,24494,49,0.84 [0.63-1.10],0.2051803995625032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,23920,49,1.07 [0.83-1.37],0.6128466051428296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,24057,47,1.59 [1.33-1.91],3.0353567321862694e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,24057,47,1.25 [0.91-1.73],0.1742041280443714
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,24596,47,2.65 [1.59-4.42],0.0001776838144389
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,24057,47,0.84 [0.53-1.34],0.4710378080984485
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,24385,49,1.81 [1.35-2.41],6.40115089976935e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,24802,48,2.35 [1.50-3.66],0.0001702318600384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,24057,47,2.99 [1.71-5.22],0.0001191486247082
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,20648,42,1.06 [0.53-2.12],0.86477127756699
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,24057,47,1.10 [0.70-1.72],0.6783468068300245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,24160,46,3.70 [1.19-11.50],0.0235953735162352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,20601,42,2.23 [0.83-5.96],0.1103075343458518
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,24494,49,3.28 [1.94-5.57],1.0203111503900531e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,24057,47,5.25 [2.91-9.46],3.469212659690066e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,24802,48,1.37 [0.83-2.27],0.2163619494533504
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,24014,47,1.73 [1.26-2.38],0.0006510215170442
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,24057,47,1.51 [1.12-2.03],0.0062953996531698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,24057,47,1.12 [0.54-2.34],0.7596153501133006
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,24057,47,0.97 [0.69-1.36],0.8593439311896776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,24494,48,1.01 [0.58-1.78],0.9614951585868188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,24177,48,1.70 [1.07-2.70],0.0243887820875771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,24385,47,2.14 [1.39-3.30],0.0005549161399037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,24560,48,5.50 [3.25-9.31],2.1081855653136914e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,24802,48,2.66 [1.33-5.32],0.0057751248844975
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,24193,49,0.83 [0.70-0.98],0.0295315921426067
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,23908,48,1.62 [1.23-2.13],0.00066925977543
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,24057,47,0.93 [0.56-1.53],0.7680634352369041
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,23939,46,0.61 [0.36-1.04],0.0708480968541483
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,24450,48,2.42 [0.87-6.71],0.0902982827766251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,24436,47,0.62 [0.18-2.17],0.4585588545907301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,24494,48,1.34 [0.76-2.37],0.3069242093462035
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,24707,49,1.53 [0.94-2.48],0.0850889347595079
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,24057,47,1.73 [0.91-3.30],0.0938117161188494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,24420,47,1.45 [1.00-2.10],0.0471742953757875
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,24057,47,1.51 [0.65-3.53],0.3423258415186883
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,24057,47,1.10 [0.69-1.75],0.6924524038782243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,24057,47,1.48 [1.01-2.16],0.0427000933202688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,20648,42,0.85 [0.42-1.73],0.6487851364398444
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,20648,42,0.68 [0.33-1.42],0.3039800125628208
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,21141,44,1.54 [1.12-2.11],0.0073943803883936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,24057,47,1.46 [0.98-2.15],0.0599078622724513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,24057,47,0.62 [0.33-1.18],0.1469825990457224
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,20425,41,0.66 [0.28-1.54],0.3349060264107398
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,24336,49,3.79 [2.46-5.84],1.4775638003484732e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,24057,47,1.38 [0.81-2.37],0.2386430282776692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,21141,44,1.50 [0.90-2.49],0.1218435470701531
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,20501,41,1.71 [0.99-2.96],0.0559196625628276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,20648,42,0.60 [0.30-1.22],0.1615029461383619
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,20578,42,1.59 [0.79-3.20],0.1929344297500496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,24494,49,1.70 [1.04-2.76],0.03265285872292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,24057,47,1.74 [0.94-3.21],0.07571249751697
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,23891,49,0.68 [0.34-1.35],0.266410517224506
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,20648,42,1.02 [0.63-1.66],0.930514464099072
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,20583,42,1.05 [0.69-1.59],0.8139097095108094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,24057,47,0.96 [0.43-2.13],0.9239609976582006
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,24057,47,1.11 [0.81-1.53],0.5214702427680068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,24494,49,2.24 [1.28-3.91],0.0047706852894482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,24057,47,0.97 [0.80-1.17],0.7302356319311147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,24494,49,0.23 [0.14-0.38],4.144832521323831e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,24385,49,1.59 [1.34-1.89],1.0361996940235881e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,24323,48,2.41 [1.16-4.98],0.0179545842199811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,24515,49,5.83 [1.84-18.51],0.0027836497085954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,24494,49,0.89 [0.60-1.32],0.5633533866809202
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,24494,48,1.12 [0.69-1.81],0.6375769007108472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,20858,44,0.44 [0.20-0.95],0.0366206158412847
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,23893,49,0.87 [0.55-1.37],0.5377931939019547
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,21141,44,1.65 [1.07-2.53],0.0225762592128709
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,24348,49,0.70 [0.45-1.07],0.1015817058468254
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,21200,44,1.06 [0.64-1.77],0.8160425186482834
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,20601,42,0.24 [0.07-0.82],0.0228806447342289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,23881,49,0.76 [0.41-1.41],0.3874513169898742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,20778,43,1.55 [0.92-2.62],0.1008559581372611
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,24494,48,2.52 [1.31-4.84],0.00558332314611
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,24385,49,1.08 [0.69-1.70],0.7305506739999588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",20668,42,0.86 [0.51-1.44],0.5578013090315171
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",21224,44,1.24 [0.69-2.23],0.4750116056988827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",24385,49,0.93 [0.72-1.20],0.5723175832795291
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,21200,44,1.03 [0.85-1.24],0.7993931830726397
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,21141,44,0.98 [0.56-1.70],0.9389148919857416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,21165,44,0.94 [0.70-1.25],0.6638656537118788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,20648,42,1.90 [0.34-10.64],0.4652401043034136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,24307,49,0.82 [0.62-1.08],0.155984653429283
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,24385,49,1.64 [1.11-2.44],0.0130843617811242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",24072,47,1.02 [0.77-1.36],0.8922342077513175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,24057,47,0.82 [0.56-1.21],0.3228951811963034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,24494,49,0.85 [0.68-1.08],0.1785529647921159
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,23561,48,0.99 [0.50-1.95],0.9659613386415584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,24494,49,2.29 [1.41-3.73],0.0008609725851939
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,21249,44,0.95 [0.49-1.83],0.87090859469829
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,21014,44,0.92 [0.69-1.22],0.5491037290028192
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,24494,49,0.97 [0.47-2.02],0.934072886255778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,20778,43,1.21 [0.51-2.84],0.6650813834141877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,24494,48,3.43 [1.34-8.77],0.0100775776255176
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,24494,49,0.65 [0.38-1.10],0.1093649582553158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,20648,42,2.69 [1.36-5.29],0.0042998398878604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,24494,48,0.95 [0.44-2.08],0.9046071094811724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,24722,48,0.47 [0.11-2.04],0.310670537615771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,20858,44,1.10 [0.65-1.85],0.7270500127843846
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,24438,48,3.04 [1.36-6.83],0.0069233350761797
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,23920,49,1.53 [0.86-2.72],0.150894952836032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,24072,47,0.86 [0.69-1.08],0.2004851434942796
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,24346,48,1.61 [0.71-3.64],0.2507488874857608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,24550,47,0.86 [0.44-1.71],0.6761228396410244
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,24057,47,1.04 [0.46-2.36],0.9168745981496615
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,24722,48,1.24 [0.73-2.09],0.4258616349442955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,21249,44,1.83 [0.89-3.78],0.1018920605718497
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,21282,44,1.38 [0.33-5.72],0.6600349918958318
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,24560,48,2.74 [1.44-5.21],0.0020655866913221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,21282,44,1.35 [0.54-3.37],0.5210912962984593
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,21141,44,0.72 [0.35-1.47],0.3701544257842335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,24494,49,1.33 [0.88-2.01],0.1726959735979127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,20594,43,1.00 [0.65-1.54],0.990202997494014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",20668,42,0.76 [0.47-1.23],0.2659295213687831
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",20601,42,0.47 [0.20-1.07],0.0711321666742129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",23928,49,1.13 [0.70-1.84],0.613632075088219
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,20501,41,0.46 [0.19-1.10],0.0814996033205218
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,24739,49,4.83 [2.28-10.23],3.889766242626597e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,20778,43,0.80 [0.44-1.47],0.4805723692672752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,24057,47,0.71 [0.47-1.08],0.1088887417160177
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,20501,41,0.63 [0.33-1.19],0.1511075734390705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,21165,44,0.80 [0.58-1.10],0.1662135524780223
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,24057,47,1.22 [0.82-1.81],0.3258559973009057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,24385,49,2.65 [1.45-4.86],0.0015487082514314
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,21165,44,0.89 [0.67-1.17],0.3883450886242612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,20601,42,0.89 [0.50-1.59],0.6947396535178266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,20672,43,0.73 [0.43-1.24],0.2427139315379912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,23928,49,0.99 [0.60-1.62],0.9602830131197598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,20785,44,1.54 [0.98-2.43],0.0601099621040216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,20648,42,0.93 [0.65-1.33],0.6761127236224046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,24550,47,2.60 [0.94-7.22],0.066378676697914
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,23928,49,1.64 [0.84-3.21],0.1461330249229944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,20501,41,0.83 [0.48-1.42],0.4925637238488249
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,20668,42,0.81 [0.52-1.27],0.3634134770984815
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,21200,44,1.05 [0.42-2.62],0.9241049193700832
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,20858,44,1.23 [0.84-1.78],0.2842672702952897
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,20858,44,0.87 [0.30-2.51],0.7947555881274608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,21141,44,1.11 [0.71-1.73],0.6601810656524397
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,20594,43,1.39 [0.79-2.45],0.2493807641223583
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,20601,42,0.85 [0.56-1.30],0.4547016685381989
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,20594,43,1.16 [0.91-1.49],0.2271789064634035
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,24385,49,0.87 [0.65-1.17],0.3654623837798941
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,21141,44,1.36 [0.98-1.90],0.0654507164644262
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,23920,49,1.34 [0.97-1.86],0.0741688723161453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,21165,44,1.00 [0.84-1.18],0.9629937367949988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,23920,49,0.88 [0.71-1.08],0.2207720357091492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,20501,41,0.77 [0.47-1.25],0.2879423055085703
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,20601,42,1.29 [0.91-1.82],0.1493840234663325
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,23928,49,1.99 [1.18-3.35],0.0095826747196454
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,24531,48,0.58 [0.25-1.34],0.2028570344266453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,24515,49,1.92 [0.96-3.87],0.0665982974919745
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,23928,49,1.09 [0.78-1.53],0.6102693784498037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,20601,42,1.51 [0.84-2.71],0.1692713658011274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,21224,44,0.86 [0.48-1.55],0.6165550870715444
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,24246,46,0.97 [0.79-1.20],0.7992327070830758
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,24477,47,2.13 [1.28-3.55],0.0035231527635022
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,24301,47,1.72 [0.82-3.64],0.153557147728691
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,23920,49,1.05 [0.88-1.27],0.5857711300086401
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,23933,49,1.75 [1.02-2.99],0.0404762989541919
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,24722,48,0.94 [0.55-1.60],0.8190571130503594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,21108,44,1.31 [0.74-2.33],0.3527477728778965
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,21249,44,1.00 [0.80-1.24],0.9847148930848498
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,24722,48,1.15 [0.79-1.68],0.4660742993571359
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,24515,47,2.30 [0.99-5.33],0.0526232521177425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,20233,43,0.65 [0.30-1.41],0.276995953767278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,23650,46,2.84 [1.57-5.13],0.0005468208680722
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,20880,44,0.50 [0.17-1.52],0.2215823810992792
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,24802,48,2.32 [1.23-4.37],0.0091972852329736
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,20601,42,0.67 [0.35-1.28],0.2259776510001955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,24802,48,2.59 [1.55-4.32],0.0002915935925709
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,20648,42,1.27 [0.76-2.13],0.3523962857894888
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,21200,44,2.83 [1.89-4.24],4.917378895851957e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",23174,48,1.47 [0.71-3.01],0.2964357464415939
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",20594,43,0.79 [0.35-1.76],0.5610973632475238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",24385,49,1.06 [0.79-1.41],0.7084213357768266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",24465,49,1.38 [0.98-1.95],0.069134914344901
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",23928,49,1.00 [0.62-1.62],0.9993152296839992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",20594,43,1.06 [0.53-2.14],0.8625827294667496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",20601,42,0.94 [0.55-1.62],0.8309361746384714
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,24465,49,0.88 [0.56-1.38],0.5830502665457455
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,24802,48,1.22 [0.72-2.06],0.4554165465292162
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,24550,47,1.18 [0.49-2.84],0.709378481852915
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,21257,44,0.94 [0.68-1.30],0.7212999160451051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,21104,44,0.83 [0.44-1.56],0.5579776439275974
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,24515,49,0.85 [0.58-1.25],0.4017515542508358
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,24385,49,2.07 [1.41-3.04],0.0002270081210454
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,24476,47,2.45 [1.66-3.62],6.304997311573196e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,24348,49,1.10 [0.86-1.42],0.4469413974456738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,20594,43,0.92 [0.52-1.64],0.7853281014675917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,24596,47,0.62 [0.28-1.36],0.2351092105061967
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,20668,42,3.62 [1.35-9.71],0.0105019676873849
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,20674,42,0.39 [0.11-1.35],0.1372980586973349
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,23764,46,1.12 [0.29-4.28],0.8725004469798675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,24754,48,2.84 [1.86-4.34],1.345896688334256e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,21141,44,0.97 [0.48-1.96],0.9403646965512548
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,24057,47,1.13 [0.68-1.90],0.6345914584885437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,21141,44,0.94 [0.59-1.49],0.7874735618545714
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,24802,48,0.89 [0.65-1.22],0.4577724090269156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,24385,49,0.96 [0.79-1.18],0.7084538926804584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,20648,42,0.89 [0.63-1.27],0.5191200855286227
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,24301,49,3.04 [1.64-5.62],0.0004084845441298
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,24560,48,1.54 [1.04-2.28],0.0307695887578788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,24739,49,0.97 [0.67-1.39],0.849567592106597
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,21262,44,5.25 [1.42-19.41],0.0130132335022643
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,21224,44,1.40 [1.01-1.94],0.0439949279891818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,23718,44,1.04 [0.51-2.11],0.9189068966202318
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,21249,44,1.53 [0.91-2.58],0.1065901501901376
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,24561,49,1.24 [0.78-1.97],0.3635123185244292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,21224,44,0.72 [0.54-0.97],0.0296628437082546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,21257,44,1.13 [0.74-1.72],0.5838495689242563
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,24690,48,1.01 [0.65-1.57],0.9682164444818464
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,20038,43,0.83 [0.54-1.27],0.3789763026617037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,20601,42,0.88 [0.56-1.38],0.5790723861113163
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,21224,44,1.69 [1.01-2.83],0.0455170035332043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEP,Leptin,24515,49,1.08 [0.83-1.40],0.5627652222447881
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,24515,49,1.24 [0.58-2.68],0.5811751203979392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,21224,44,1.08 [0.64-1.82],0.7701025390605634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,24515,49,2.82 [1.56-5.10],0.0006166611593093
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,24558,49,1.20 [0.52-2.77],0.6608209778379209
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,21282,44,1.37 [0.59-3.17],0.4572636509000811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,24476,47,1.60 [1.03-2.48],0.0357316169438031
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,24467,47,1.42 [0.84-2.41],0.194473392376239
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,24739,49,0.90 [0.59-1.37],0.6290923277477907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,24473,47,5.78 [3.22-10.38],3.989413551137457e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,24596,47,0.65 [0.32-1.34],0.2410463846169496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,23920,49,1.10 [0.85-1.42],0.4511388385170184
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,24508,47,1.00 [0.65-1.52],0.9946215423946816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,23928,49,1.25 [0.84-1.88],0.271314519584614
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,24494,49,1.47 [0.57-3.80],0.4305581561170645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,24494,48,1.64 [0.80-3.38],0.1802608236344945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,21249,44,2.18 [1.20-3.97],0.0109747981213457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,20594,43,1.15 [0.69-1.92],0.6044721672495805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,24487,49,2.96 [1.48-5.94],0.0021592236523616
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,21257,44,1.14 [0.77-1.68],0.5205368661645087
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,24797,49,4.07 [1.69-9.80],0.001744764250503
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,24660,49,3.13 [1.54-6.38],0.0016594126056023
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,24057,47,2.90 [1.70-4.94],8.855742023554993e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,24797,49,1.56 [1.02-2.37],0.0381036554473574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,20668,42,1.43 [0.92-2.23],0.1133909014978934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,21120,44,1.28 [0.88-1.86],0.2037381188995093
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,21200,44,3.56 [1.97-6.44],2.733824370097904e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,21224,44,1.69 [0.97-2.92],0.0621431538628318
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,20601,42,0.63 [0.36-1.11],0.1120227224890258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",20668,42,1.03 [0.74-1.44],0.8579218911262032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),20767,42,1.21 [1.02-1.44],0.0291077372234332
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,24385,49,1.17 [0.73-1.88],0.5023681588135123
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,24515,49,1.13 [0.71-1.82],0.6024518227289242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,23731,47,1.46 [0.98-2.18],0.0612187700348814
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,20594,43,0.76 [0.48-1.18],0.217189233024087
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,20594,43,0.74 [0.47-1.17],0.1993060445849496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,20672,43,0.95 [0.51-1.77],0.866434223508916
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,21282,44,3.75 [1.67-8.41],0.0013722243052852
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,24659,48,2.75 [1.45-5.22],0.0019840241243129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,20577,42,1.89 [1.08-3.33],0.0266259214484049
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,24385,49,2.54 [1.10-5.84],0.0283272555043795
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,24515,49,3.50 [1.91-6.41],4.794437953158454e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,20672,43,0.62 [0.25-1.53],0.3015068169867069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,20672,43,0.74 [0.45-1.20],0.2223654301836115
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,24739,49,0.97 [0.62-1.52],0.8828010303822413
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,24385,49,1.74 [1.05-2.87],0.0308877256289337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,21165,44,0.91 [0.46-1.79],0.7827323926068513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,20672,43,0.71 [0.37-1.36],0.3036985119235303
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,21257,44,0.90 [0.48-1.70],0.7480658234594859
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,21141,44,0.88 [0.48-1.63],0.6898975373019799
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,24057,47,0.87 [0.46-1.65],0.6637964262162628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,20672,43,1.48 [0.89-2.48],0.1335250231723575
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,21224,44,1.12 [0.40-3.15],0.825136244924423
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,23920,49,1.04 [0.67-1.61],0.8741605394758643
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,20858,44,1.19 [0.91-1.56],0.2017846121802756
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,24494,49,1.05 [0.58-1.92],0.8680723015017774
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,24494,49,1.39 [0.78-2.51],0.2651149365849404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,24722,48,1.38 [0.95-2.01],0.0917937187775357
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,21141,44,1.10 [0.50-2.42],0.8149259399610207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,24797,49,3.32 [1.70-6.49],0.0004366358557941
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,23920,49,1.47 [1.07-2.03],0.0178265416868948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,24337,47,5.77 [2.99-11.14],1.8123698712242909e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,24057,47,0.61 [0.29-1.28],0.189052500264501
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,21141,44,2.01 [1.37-2.93],0.0003182675419508
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LXN,Latexin,24230,48,1.00 [0.69-1.45],0.9880521618371034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,24336,47,2.73 [1.79-4.17],3.384754797014499e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,24494,49,1.31 [0.67-2.57],0.4243081725233775
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,24267,48,0.90 [0.37-2.20],0.816202295649576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,24348,49,0.40 [0.19-0.87],0.0201207660607012
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,23920,49,1.18 [0.80-1.72],0.4078703881576955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,24385,49,0.92 [0.69-1.23],0.565243332846014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,23928,49,0.70 [0.39-1.23],0.2132848376953648
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,24365,47,1.46 [0.72-2.98],0.2935012861168563
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,23920,49,1.22 [0.79-1.88],0.3755261205624106
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,20601,42,0.91 [0.66-1.25],0.557156502547564
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,20672,43,0.90 [0.66-1.24],0.5189601813080867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,21282,44,2.78 [0.66-11.73],0.164860356721835
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,20501,41,0.46 [0.19-1.12],0.0868628694934071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,20778,43,0.83 [0.55-1.26],0.3783755877797343
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,20668,42,0.57 [0.22-1.49],0.2527828718760246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,24269,48,1.04 [0.64-1.70],0.8628301609358879
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,23920,49,1.64 [1.09-2.48],0.0188415082098571
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,20672,43,0.58 [0.32-1.05],0.0725630519654724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,20858,44,1.26 [0.88-1.80],0.207135655608712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,23920,49,0.87 [0.50-1.51],0.6153350377192515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,21257,44,2.44 [1.12-5.29],0.0245942820414633
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,21141,44,0.70 [0.41-1.19],0.1856388705403091
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",20668,42,3.47 [1.18-10.19],0.0236804911571296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,21257,44,1.14 [0.71-1.85],0.5899664841110762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",20501,41,1.39 [0.83-2.33],0.2165046984026796
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,24596,47,0.89 [0.73-1.08],0.2475794881555598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,24550,47,4.76 [2.24-10.09],4.723243880723795e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,20594,43,0.86 [0.53-1.40],0.5484537443343177
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,20601,42,1.20 [0.48-2.99],0.6912444040173187
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,20594,43,1.21 [0.86-1.70],0.2801615149805447
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,21200,44,0.99 [0.53-1.86],0.9774236338611572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,21165,44,0.89 [0.57-1.40],0.6246892705427418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,24494,49,0.86 [0.67-1.10],0.2284557643128051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,23920,49,0.99 [0.77-1.29],0.9542817553594478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,24301,49,0.89 [0.71-1.11],0.290336646034234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,20501,41,0.80 [0.39-1.65],0.5460825954995288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,24494,49,0.62 [0.35-1.10],0.1019690433360266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,20858,44,0.78 [0.52-1.16],0.2159348519076821
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,20501,41,1.08 [0.89-1.30],0.428149598348176
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,23928,49,0.89 [0.56-1.42],0.6212397100504994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,24515,49,2.02 [0.77-5.28],0.1501776129647825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",20732,43,0.82 [0.58-1.16],0.2733568316276412
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,24301,49,0.53 [0.19-1.50],0.2289839970068746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,24520,47,1.38 [0.60-3.21],0.4499461706023276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,24307,49,1.77 [0.83-3.81],0.141784208397433
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,23920,49,0.99 [0.75-1.30],0.9353386079043108
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAX,Protein max,23928,49,0.87 [0.68-1.11],0.2754757294054512
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,24797,49,1.42 [0.99-2.04],0.0592377803720727
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,20982,43,0.99 [0.76-1.29],0.9430976959206636
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,24560,48,2.88 [1.60-5.20],0.0004427619058139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",21224,44,1.28 [0.74-2.21],0.3721883944859085
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,20648,42,0.88 [0.62-1.23],0.4390192293855043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,24406,48,0.73 [0.41-1.31],0.2932052389153591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,21165,44,0.86 [0.27-2.77],0.8008392100874494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,24348,49,1.14 [0.80-1.63],0.4741685195157126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",21139,44,0.92 [0.45-1.88],0.8269634232471597
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDK,Midkine,24470,47,1.02 [0.62-1.68],0.9299405673107608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,20672,43,0.47 [0.17-1.26],0.1336273800393718
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",20668,42,0.96 [0.69-1.32],0.7992550318470337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,23920,49,0.84 [0.60-1.17],0.3014610805652936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,20594,43,0.64 [0.29-1.41],0.2689465057952123
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,24476,47,1.34 [0.72-2.50],0.3595887314278628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,20594,43,1.22 [0.54-2.74],0.6301989229627663
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,24707,49,2.09 [0.78-5.61],0.1453188986388906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,21257,44,0.79 [0.30-2.06],0.6282687196129237
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,20778,43,3.07 [0.87-10.80],0.0812072632323893
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,21165,44,1.05 [0.71-1.54],0.809770512787833
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,24515,49,0.98 [0.79-1.21],0.8471966152513881
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,24476,47,1.22 [0.45-3.31],0.6995555963362092
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,24802,48,2.09 [0.82-5.31],0.122307472070854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,24494,48,0.86 [0.70-1.06],0.1602980074955151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,24554,49,2.21 [0.63-7.81],0.2175547509648847
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,23928,49,1.07 [0.47-2.42],0.8743961923694614
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",24494,49,0.83 [0.61-1.13],0.2491708484968334
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,24690,48,0.90 [0.59-1.38],0.6352072900090693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,24072,47,1.13 [0.70-1.83],0.6186714126603723
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,20672,43,1.08 [0.72-1.63],0.7011845347248191
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,20778,43,1.37 [0.56-3.35],0.4922162346895362
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,24797,49,0.99 [0.54-1.82],0.969631539693816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,24494,48,1.34 [0.77-2.34],0.2945274036127928
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,24561,47,0.78 [0.59-1.02],0.0692986724096789
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,24494,49,0.93 [0.77-1.14],0.5045370730550136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,24550,47,2.73 [1.55-4.80],0.0004812050303438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,20672,43,1.00 [0.65-1.54],0.9907759811297978
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,24494,49,1.13 [0.92-1.38],0.2402864043278312
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,24451,48,0.81 [0.56-1.17],0.259683353794418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,24057,47,1.82 [1.15-2.88],0.010455119638775
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,21141,44,0.94 [0.72-1.22],0.6263288793131587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,21200,44,0.89 [0.66-1.21],0.4606936378721556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,24348,49,0.81 [0.63-1.04],0.0977517614530839
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,20648,42,1.12 [0.57-2.20],0.7438780501888596
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,20501,41,0.77 [0.47-1.28],0.3102277858453069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,24494,49,1.38 [1.04-1.82],0.0247381706834991
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,24385,49,1.16 [0.87-1.56],0.3142586850677502
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,23632,44,0.77 [0.59-1.02],0.0716843165571583
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,24453,47,1.01 [0.66-1.55],0.9503426941573312
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,24546,48,2.11 [1.41-3.18],0.0003114463854694
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,23928,49,2.28 [1.05-4.93],0.0368199204033693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,21257,44,1.38 [0.96-1.98],0.0862185458984329
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,24494,48,1.26 [0.84-1.88],0.2609743527007764
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,24033,47,1.28 [0.74-2.19],0.3774844747386493
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,24701,49,1.04 [0.74-1.45],0.8390877594578586
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,24461,48,0.89 [0.59-1.33],0.5623718313271909
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",20594,43,0.49 [0.25-0.98],0.0420834235379361
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,20672,43,0.72 [0.39-1.32],0.2858237985678151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,20858,44,0.71 [0.34-1.47],0.3537332925493415
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,24479,48,0.99 [0.77-1.27],0.9251844942648156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,20778,43,1.03 [0.67-1.58],0.8775101002277542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,24722,48,1.74 [0.80-3.81],0.1636394781285409
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,21200,44,0.67 [0.21-2.15],0.4957846239741309
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,20858,44,0.83 [0.38-1.82],0.6394785068128899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,20501,41,1.45 [0.75-2.79],0.2665748137161777
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,20501,41,1.02 [0.71-1.47],0.8941217639527511
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,24072,47,0.79 [0.55-1.13],0.189145593332115
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,24385,49,0.98 [0.73-1.31],0.8814021111389492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,24561,47,0.88 [0.64-1.20],0.4056663356944998
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,24494,48,1.23 [0.74-2.04],0.4201657739668684
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,21106,44,1.08 [0.57-2.02],0.8194422639793789
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,21262,44,2.83 [1.12-7.16],0.0274133895472168
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,20672,43,1.01 [0.66-1.55],0.963845513265168
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",20594,43,0.76 [0.32-1.79],0.5308137147186147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",21224,44,0.36 [0.10-1.35],0.1292796800332177
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",23928,49,0.41 [0.15-1.16],0.0930786881551408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",20465,41,0.55 [0.16-1.88],0.3429614319657594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",21224,44,0.86 [0.55-1.36],0.526953221884636
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",20648,42,1.76 [0.89-3.47],0.1046268765184376
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,24354,49,1.89 [1.29-2.77],0.0011959032330188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,20672,43,0.78 [0.33-1.81],0.558516591607974
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,24426,48,1.17 [0.82-1.66],0.3860999826143959
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,24739,49,2.52 [1.54-4.12],0.0002193139164926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,24550,47,0.87 [0.61-1.23],0.427825427678321
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,20956,44,0.92 [0.62-1.36],0.6647963840886142
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,24072,47,1.18 [0.76-1.82],0.4541144263994949
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,20648,42,0.98 [0.71-1.35],0.8903794931215162
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",21200,44,0.59 [0.16-2.14],0.4202526962259055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,20858,44,0.88 [0.68-1.14],0.3282448224455739
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",21165,44,0.83 [0.59-1.15],0.2606519802105492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,24072,47,0.82 [0.35-1.90],0.6405355982101846
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,20594,43,1.11 [0.74-1.67],0.6197290358400613
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,21165,44,0.95 [0.73-1.23],0.6697616541466617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,21141,44,0.81 [0.61-1.09],0.1644950972952289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,20858,44,1.24 [0.80-1.93],0.3280178586437943
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,23928,49,1.43 [0.89-2.30],0.1405084017675299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,24385,49,1.07 [0.93-1.24],0.3505196779220582
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,21249,44,1.06 [0.78-1.44],0.7328278404159224
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,20501,41,1.11 [0.59-2.08],0.7559583430427437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,24057,47,0.94 [0.68-1.31],0.7246227421473468
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,20778,43,0.66 [0.26-1.65],0.3705536408134942
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",21257,44,1.44 [1.04-1.98],0.0272610850421027
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",20668,42,1.22 [0.93-1.60],0.1584085094872754
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,21224,44,0.90 [0.58-1.41],0.6434425363601579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,21257,44,0.87 [0.66-1.16],0.3564287377349763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,20594,43,1.17 [0.68-2.01],0.5761573704292815
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,20501,41,0.72 [0.33-1.61],0.4277874295704641
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,21249,44,1.04 [0.81-1.34],0.7594877751178868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",20594,43,0.74 [0.32-1.69],0.4746954624636331
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,20668,42,1.38 [0.97-1.97],0.069463807028694
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,20668,42,1.49 [0.99-2.25],0.0556249265320365
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,20672,43,0.93 [0.66-1.31],0.6871752896717216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",20672,43,1.14 [0.69-1.90],0.6010814559808204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,21224,44,1.15 [0.59-2.25],0.6792945104657581
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,24057,47,1.07 [0.74-1.56],0.7163391568831464
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,24494,48,0.88 [0.51-1.51],0.6486859410598542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,20601,42,0.52 [0.22-1.21],0.1291924861890676
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,20594,43,0.90 [0.50-1.62],0.7291836027897967
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,20778,43,1.11 [0.83-1.47],0.4813751699744539
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,24555,47,0.47 [0.28-0.78],0.003916394800921
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,23920,49,0.92 [0.56-1.52],0.7399903023813457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,20594,43,0.88 [0.50-1.56],0.6577200316843059
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,20672,43,0.89 [0.69-1.13],0.3354664037014673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,24236,47,0.96 [0.63-1.48],0.8692100016659186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,21141,44,1.17 [0.72-1.90],0.5296488605370397
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,24515,49,1.18 [0.79-1.75],0.4188232203874525
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,20614,42,1.01 [0.62-1.65],0.971136535454199
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,20630,42,0.62 [0.37-1.06],0.0792225175281003
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,20778,43,5.97 [1.55-22.92],0.0092895632851945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,23920,49,1.14 [0.76-1.71],0.5347003810081188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,21129,44,1.25 [0.61-2.53],0.5447758922385967
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,21200,44,1.05 [0.44-2.49],0.9092251168086468
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",21224,44,1.01 [0.56-1.85],0.961975070121028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,24550,47,3.97 [1.67-9.44],0.0017797171819503
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,24057,47,1.10 [0.71-1.70],0.6796024443021396
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,24560,48,2.74 [1.41-5.32],0.0028137396536705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,24494,48,1.07 [0.42-2.75],0.8894583955084829
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,24739,49,1.33 [0.69-2.56],0.3961078441831962
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,24453,49,0.98 [0.73-1.31],0.8661466661956123
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,24596,47,0.83 [0.65-1.05],0.118945389048144
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,24057,47,1.21 [0.84-1.76],0.3100786493686543
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,24461,49,4.14 [2.24-7.63],5.677286721615638e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,21165,44,3.46 [1.89-6.32],5.45356143523972e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,24722,48,3.21 [1.39-7.45],0.0065412288514782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,23928,49,0.75 [0.46-1.21],0.2381500882371496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,21141,44,0.69 [0.37-1.27],0.2316863487262392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,20603,42,1.36 [0.62-2.98],0.4475994692348779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,21165,44,0.73 [0.52-1.02],0.0663636736039051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",23920,49,1.20 [0.94-1.53],0.1428242383788273
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,20594,43,1.44 [0.81-2.56],0.217067897925917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,20594,43,0.74 [0.45-1.21],0.2250560200597658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,20648,42,1.56 [0.77-3.13],0.2155169128769563
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,24487,49,4.63 [2.42-8.87],3.753478002347582e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,24550,47,2.86 [1.55-5.30],0.0008186210416073
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,20648,42,0.81 [0.45-1.46],0.4821526637182567
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,20648,42,1.42 [0.72-2.78],0.310993100067419
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,23851,49,2.83 [2.00-4.00],4.305784901355904e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,20858,44,0.98 [0.65-1.46],0.9102541029180722
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,24550,47,1.10 [0.59-2.06],0.7589192906510845
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,24596,47,0.48 [0.19-1.20],0.1177653809421996
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,21141,44,1.15 [0.93-1.43],0.2045847011309374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,21224,44,1.57 [0.53-4.66],0.4161735289930571
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,21262,44,1.09 [0.72-1.65],0.6723976913248104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,24802,48,2.28 [0.96-5.39],0.060924237652678
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,20648,42,0.89 [0.61-1.28],0.5142055257537604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",24494,49,0.80 [0.61-1.04],0.0955250970452307
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",24057,47,1.01 [0.65-1.55],0.9708417989943792
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,20668,42,0.93 [0.62-1.39],0.7264603862936554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,21224,44,0.43 [0.15-1.25],0.1215962163740393
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,20594,43,0.81 [0.54-1.21],0.3026333736884239
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,20858,44,0.75 [0.38-1.49],0.4121577012192583
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,23920,49,0.95 [0.56-1.60],0.8382518473315053
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",21165,44,0.91 [0.69-1.20],0.5199202427918277
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,20594,43,0.91 [0.58-1.43],0.6941785181841699
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,20594,43,0.83 [0.36-1.90],0.6537002863186369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,24348,49,1.45 [0.22-9.43],0.6991391585329998
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,21257,44,0.91 [0.33-2.50],0.8485336458507399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,21200,44,0.85 [0.22-3.29],0.8172255611012262
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,20295,43,1.79 [0.71-4.50],0.2156827724075725
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,24489,48,1.31 [0.69-2.49],0.4101146999630822
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,24494,48,0.84 [0.59-1.19],0.3244123509559626
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,23920,49,1.08 [0.72-1.62],0.7079355339125225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,20668,42,0.74 [0.41-1.33],0.3156536143197044
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,21180,44,0.84 [0.58-1.22],0.3669475192963097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,20672,43,0.90 [0.56-1.45],0.6615488915527374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,20601,42,1.30 [0.79-2.12],0.2983018839417767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,20648,42,1.01 [0.25-4.08],0.9889716955727412
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,24520,47,0.67 [0.21-2.14],0.4993606536776728
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,21054,44,1.19 [0.82-1.73],0.3567776619323429
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,24348,49,1.17 [0.88-1.56],0.2744976751843972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,20501,41,0.33 [0.11-1.03],0.055482442218033
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,21224,44,1.40 [1.02-1.91],0.0368371608597488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,24494,48,2.95 [1.33-6.54],0.0079696278368238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,20594,43,0.90 [0.66-1.22],0.4981934931630581
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",23928,49,1.40 [0.94-2.09],0.0978598542063458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",20594,43,1.31 [0.69-2.51],0.4135548861959678
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",23928,49,1.95 [1.51-2.52],3.0549856311759137e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,24797,49,,
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,21249,44,0.90 [0.26-3.05],0.8625868037080098
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,24797,49,1.75 [0.88-3.48],0.1085238394772957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,20897,43,1.91 [1.02-3.57],0.0441210161179613
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,24515,49,3.10 [1.84-5.22],2.2345145696931587e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,20648,42,2.11 [1.35-3.30],0.0010188257348909
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,20648,42,0.69 [0.47-1.02],0.0649295317000526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,21257,44,2.12 [1.27-3.55],0.0040721847331486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,24072,47,0.98 [0.80-1.19],0.8148711223661591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,24494,49,1.37 [0.87-2.16],0.1694447107559885
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,20594,43,0.46 [0.17-1.22],0.117831346981177
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,23920,49,1.12 [0.86-1.45],0.4049661212223062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,24494,48,2.11 [1.35-3.27],0.0009417557903476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,21249,44,0.72 [0.35-1.47],0.3619744528765649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,24515,49,1.49 [0.77-2.91],0.2373630439542654
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,24722,48,1.08 [0.74-1.57],0.6910520479387159
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,24515,49,3.75 [1.70-8.31],0.0011093774496837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,21262,44,0.74 [0.54-1.01],0.0592713209099341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,21224,44,0.61 [0.22-1.73],0.3541148055784818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,24613,48,3.66 [1.64-8.17],0.0015146676371511
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,24494,48,2.61 [1.32-5.13],0.0055834324941181
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,24057,47,1.65 [1.20-2.27],0.0020977599971811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,20672,43,1.13 [0.52-2.48],0.7505018523367832
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,24739,49,0.94 [0.65-1.37],0.7645385518507194
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",21257,44,1.01 [0.69-1.48],0.9551484762330557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,21200,44,2.55 [1.69-3.85],8.20343932741088e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,24451,49,0.88 [0.67-1.17],0.3836072024477517
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,24550,47,1.45 [0.96-2.17],0.0740954598185365
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,24494,49,1.13 [0.56-2.31],0.7306047417399033
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,23920,49,0.92 [0.45-1.87],0.8163008216307777
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,24515,49,2.71 [1.03-7.10],0.0432037968811607
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,24739,49,2.03 [0.65-6.36],0.2239342548314719
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,24515,49,1.19 [0.93-1.52],0.1630486166820802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,24494,49,0.84 [0.61-1.14],0.2640781770643466
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,21141,44,1.19 [0.93-1.53],0.1636019469755483
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,24687,48,0.85 [0.43-1.67],0.6374945901910847
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,24802,48,0.90 [0.62-1.33],0.6107401176283691
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,20668,42,0.88 [0.26-2.95],0.8321450978197111
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,20594,43,1.40 [0.96-2.04],0.0842921707827784
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,21133,44,1.11 [0.81-1.52],0.5311755511987559
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],24385,49,0.73 [0.46-1.16],0.1822861353510196
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,24494,48,0.96 [0.59-1.57],0.878440809794869
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,20648,42,0.84 [0.60-1.20],0.343129694489986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,20594,43,0.93 [0.36-2.39],0.8833492504622712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,20594,43,0.81 [0.31-2.11],0.6712358698354988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,23928,49,1.62 [1.03-2.55],0.0383789977763858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,20648,42,0.69 [0.26-1.80],0.4448345393597213
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,24267,49,0.78 [0.56-1.08],0.1334950955190214
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,21224,44,1.93 [1.15-3.25],0.0131261825922794
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,23891,49,1.19 [0.78-1.80],0.4266382098158939
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,20858,44,0.85 [0.52-1.41],0.5329280944078535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,21165,44,0.78 [0.51-1.18],0.231700385533654
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,24385,49,1.57 [0.77-3.23],0.2153890978755028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,24494,48,2.26 [1.30-3.93],0.0038541063530652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,20858,44,0.94 [0.58-1.52],0.7897739349194876
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,20015,42,1.15 [0.90-1.47],0.2615445733603064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,24266,48,0.81 [0.52-1.26],0.3567811773607876
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,24596,47,2.45 [1.32-4.54],0.0043889488496427
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,24385,49,0.77 [0.53-1.13],0.1841485507290744
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,20601,42,1.09 [0.62-1.92],0.7606206907517149
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,21200,44,0.83 [0.63-1.08],0.1619404881245002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,20668,42,0.90 [0.58-1.39],0.6389609862331909
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,24385,49,2.08 [1.60-2.70],4.6210211157310376e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,21208,44,9.72 [3.80-24.85],2.038447524120369e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,21200,44,1.34 [0.79-2.26],0.2802071249476373
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,24520,47,2.83 [1.32-6.08],0.0075418938600961
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,24363,49,1.07 [0.76-1.50],0.7005881449620701
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,24613,48,6.84 [2.71-17.25],4.691067731542623e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,20672,43,0.64 [0.27-1.52],0.3101522624961058
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,20601,42,0.83 [0.43-1.58],0.5647603325420301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,21165,44,0.89 [0.54-1.46],0.6450853181984937
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,21224,44,0.93 [0.60-1.46],0.7586093201492572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",20668,42,0.94 [0.62-1.44],0.7799809418566244
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,24739,49,0.91 [0.76-1.09],0.3048223654786508
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,24358,47,1.23 [0.64-2.34],0.5330925199865075
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,20594,43,0.81 [0.49-1.31],0.3859909282127175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,24057,47,1.35 [1.02-1.79],0.0354523643122631
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,23891,49,0.82 [0.56-1.22],0.327956305617696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,24348,49,0.76 [0.61-0.94],0.0108462002155329
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,21224,44,1.23 [1.03-1.48],0.024438665904741
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",20858,44,0.55 [0.29-1.04],0.0658608245937247
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,24072,47,1.15 [0.74-1.78],0.5471247005818108
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,20668,42,0.46 [0.21-1.01],0.0517604405919786
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,20458,41,1.01 [0.57-1.79],0.975361990116692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,23928,49,0.79 [0.51-1.24],0.3111803990454207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,20648,42,1.37 [0.77-2.41],0.281329275890398
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,21050,44,3.44 [1.88-6.30],6.281427030168002e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,21200,44,2.24 [1.34-3.75],0.0020298014669215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,20594,43,1.27 [0.98-1.65],0.0705943144731157
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,24670,49,2.12 [0.81-5.54],0.1261763833313861
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,24494,48,1.85 [0.74-4.64],0.1872668935602907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,24057,47,0.77 [0.46-1.30],0.3331009519210074
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,20858,44,1.15 [0.80-1.64],0.4501310253888234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,24494,48,0.92 [0.57-1.48],0.7208467311352673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,24494,49,1.11 [0.75-1.65],0.595189340937715
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,20778,43,1.17 [0.64-2.14],0.6070801994498911
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,20501,41,1.54 [0.61-3.89],0.3573159939170957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,23928,49,0.96 [0.59-1.57],0.8711658875438014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,21165,44,0.73 [0.27-1.99],0.5414830384571634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,20601,42,1.32 [1.07-1.63],0.0106178672912725
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,20728,43,1.19 [0.67-2.10],0.5544103238270184
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,21224,44,0.87 [0.58-1.29],0.4816374792946792
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,24719,48,1.07 [0.33-3.42],0.909885452602682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,21224,44,1.82 [0.77-4.32],0.1731292308432583
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,24515,49,3.09 [1.68-5.66],0.0002633026251531
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,21165,44,0.87 [0.36-2.13],0.7632104931786164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,21165,44,2.53 [1.09-5.91],0.0313235039790995
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,21141,44,1.09 [0.55-2.19],0.8013337736147058
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,20501,41,0.91 [0.55-1.51],0.7176218427619342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,21141,44,1.30 [0.76-2.22],0.3407250359937468
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,24797,49,1.38 [0.73-2.58],0.3205056441769538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,21165,44,0.74 [0.51-1.07],0.1043167574097626
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,21257,44,0.76 [0.57-1.02],0.0689182503413713
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,24687,48,4.02 [2.70-6.00],8.410145115851124e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,24385,49,2.61 [1.29-5.30],0.0078139766595041
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,24739,49,1.05 [0.69-1.60],0.8061144089027351
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,24515,49,1.34 [0.85-2.12],0.2094614943200257
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,20501,41,0.57 [0.26-1.23],0.1515011544722395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",20501,41,0.56 [0.25-1.25],0.1554678004405016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",20594,43,0.72 [0.39-1.34],0.2968252956657761
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",20778,43,0.95 [0.72-1.26],0.7447737269097423
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,24797,49,0.63 [0.45-0.88],0.0073471917081434
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,24596,47,0.69 [0.52-0.92],0.0111050632287821
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,23920,49,2.31 [1.20-4.46],0.0124554692159735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,24515,49,2.69 [1.24-5.83],0.0125356412758517
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,24797,49,1.88 [0.89-3.97],0.0956295086194889
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,20501,41,0.40 [0.16-0.99],0.0486938149426042
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,20778,43,1.26 [0.47-3.42],0.6485410935644074
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,21249,44,0.75 [0.46-1.22],0.2461077728107344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,20501,41,0.87 [0.51-1.47],0.5973282864631073
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,21224,44,0.91 [0.72-1.14],0.4069337348074645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,24596,47,0.92 [0.75-1.13],0.4178090689806321
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",23920,49,0.84 [0.48-1.45],0.5259152623945706
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,20672,43,1.30 [0.85-1.97],0.2246723361538938
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,20501,41,0.65 [0.29-1.45],0.2949403799540295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,20594,43,0.99 [0.61-1.60],0.9688495712108108
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,20648,42,1.50 [0.90-2.50],0.1168430360490846
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,24797,49,1.56 [0.51-4.72],0.4344291638953557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,24494,48,0.96 [0.63-1.47],0.8513149330598242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,24494,48,0.74 [0.31-1.74],0.4900979286584629
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,20668,42,0.62 [0.20-1.96],0.4153386262698773
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,20778,43,1.51 [0.64-3.53],0.346480614408673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,21262,44,0.90 [0.30-2.70],0.8547282214787497
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,20648,42,1.05 [0.82-1.34],0.7173242257321837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,21121,44,0.80 [0.60-1.06],0.1230851866875979
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,23928,49,0.91 [0.57-1.46],0.705997170375857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,20501,41,1.01 [0.59-1.74],0.9592498869397924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,20672,43,0.78 [0.45-1.36],0.3823427520620134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",24351,49,0.85 [0.61-1.17],0.3160805419200959
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,21262,44,1.33 [0.84-2.09],0.2230313136287678
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",21257,44,1.00 [0.60-1.67],0.9941760761440386
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,24802,48,2.61 [1.75-3.91],2.7832162978503864e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,24660,49,0.59 [0.31-1.12],0.1063643633700488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,21005,43,0.43 [0.18-1.03],0.0573141711599682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,20594,43,0.80 [0.46-1.41],0.4460540794322097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,20672,43,0.85 [0.48-1.52],0.5907173792886239
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,20648,42,0.98 [0.73-1.32],0.9113660053720768
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,21224,44,0.88 [0.69-1.13],0.3317436420454007
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,21165,44,1.75 [1.09-2.80],0.0202973152353289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,20501,41,0.92 [0.64-1.32],0.6434817300367082
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,24348,49,3.23 [1.50-6.95],0.0027807523492595
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,20778,43,0.92 [0.46-1.83],0.8080391298948612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,21262,44,2.35 [0.73-7.56],0.1507832845737183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PI3,Elafin,24156,48,1.69 [1.20-2.37],0.0025566515071832
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",21224,44,0.71 [0.48-1.04],0.0822303568021711
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,24193,48,1.59 [0.85-2.97],0.1486916511931055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,24494,49,1.08 [0.72-1.61],0.7164984376598713
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,24494,48,4.72 [2.48-8.99],2.370268215120103e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,20648,42,1.25 [0.82-1.93],0.3019883527767636
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,24494,48,3.00 [1.68-5.37],0.0002047852923568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,24515,49,1.94 [1.19-3.17],0.0082148346298951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,20778,43,0.72 [0.48-1.09],0.1183660605979952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,20458,41,0.50 [0.28-0.90],0.0207246556906184
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,21257,44,1.30 [0.44-3.85],0.6372695814392277
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,20594,43,1.40 [0.94-2.09],0.0981877614348705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,24510,47,1.27 [0.88-1.82],0.2032518701046892
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,20858,44,0.80 [0.53-1.20],0.2825645457527613
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,24348,49,1.35 [0.89-2.05],0.1640654197021304
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,24550,47,2.03 [0.82-5.03],0.1279966347887496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,24754,49,2.11 [1.24-3.60],0.0060812772555133
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",24440,49,1.27 [0.89-1.82],0.1879633638835034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,24596,47,0.87 [0.65-1.16],0.3503097099921893
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,24494,48,2.68 [1.18-6.09],0.0185036198604705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,24707,49,1.33 [0.83-2.14],0.241395616260387
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,24494,48,1.45 [0.70-2.99],0.31418339476579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,24312,47,2.33 [1.02-5.31],0.0444228454166416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",21200,44,0.91 [0.58-1.42],0.6638322089616706
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",20648,42,0.85 [0.42-1.73],0.6584744276481759
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",21200,44,0.86 [0.64-1.14],0.2907875905774847
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,21200,44,0.83 [0.54-1.27],0.3931525284697332
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,20726,43,0.36 [0.10-1.21],0.098553715719547
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,23928,49,1.52 [0.82-2.80],0.1820697616593967
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,24515,49,1.01 [0.57-1.79],0.980100846831382
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,24515,49,0.83 [0.57-1.21],0.335497157174276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,21169,44,0.89 [0.55-1.44],0.6391482686941634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,24703,49,1.76 [0.86-3.61],0.1212354840366465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,23920,49,1.23 [0.70-2.17],0.4792673911310544
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,21200,44,0.72 [0.24-2.14],0.5491420214154223
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,24494,49,0.85 [0.62-1.15],0.2805258767452891
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,24680,49,1.99 [0.72-5.49],0.1817885670796045
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,24434,48,0.54 [0.31-0.95],0.0316377646363807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,24421,49,0.95 [0.84-1.08],0.43896006979976
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,20594,43,0.68 [0.39-1.19],0.1738418008652958
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,20594,43,0.73 [0.44-1.22],0.2301170955846173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,20672,43,1.11 [0.64-1.92],0.7126789877591073
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,23890,49,0.87 [0.71-1.06],0.1692087677112738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,21262,44,1.28 [0.83-1.97],0.2727078275506515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,21200,44,1.76 [1.26-2.45],0.0009348736391576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,24476,47,0.95 [0.88-1.03],0.2264080656375965
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,20668,42,0.80 [0.47-1.38],0.4260541626577628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,20601,42,0.88 [0.44-1.79],0.7316038625588988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",24057,47,0.68 [0.51-0.93],0.013900235166754
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,24385,49,5.67 [1.09-29.58],0.0396092339793355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,24550,47,4.42 [1.99-9.85],0.0002684675620986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,20648,42,1.20 [0.67-2.17],0.5351068006793536
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,20648,42,1.21 [0.47-3.07],0.6948364085008232
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",24385,49,1.45 [0.85-2.47],0.1720830068024074
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,20668,42,0.70 [0.47-1.06],0.0911419850095619
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,21262,44,0.53 [0.21-1.33],0.1775844280299953
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,24072,47,1.41 [0.68-2.93],0.3595211410679166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,24596,47,0.95 [0.42-2.15],0.9019641434042484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,21249,44,0.92 [0.43-1.97],0.8375370070556186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,21113,44,0.73 [0.53-1.01],0.0601872426208578
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,24739,49,1.06 [0.63-1.78],0.8368357424639782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,24485,49,0.84 [0.65-1.09],0.192600371527762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,20858,44,0.76 [0.42-1.37],0.3678046387098513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",21249,44,0.65 [0.38-1.11],0.1130608192848673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,20648,42,1.41 [0.65-3.06],0.3817282173124822
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,23920,49,2.06 [1.30-3.28],0.0021196417289352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,20648,42,1.02 [0.64-1.61],0.9416417264861984
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,21257,44,0.81 [0.47-1.40],0.446372878672496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,24385,49,1.07 [0.71-1.61],0.7487145125805708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,21141,44,0.90 [0.63-1.27],0.5472252349509762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,24550,47,0.90 [0.69-1.18],0.4517133811078594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,20858,44,1.01 [0.68-1.51],0.9543881443647744
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,21224,44,0.77 [0.53-1.14],0.1894188005477303
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,21224,44,2.26 [1.45-3.53],0.0003164973432164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,24515,49,0.80 [0.58-1.11],0.1807823506214395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,24802,48,1.10 [0.84-1.43],0.4874052974169477
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,21165,44,0.91 [0.71-1.17],0.4671062913042848
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,24348,49,0.76 [0.42-1.40],0.3835279474910094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,20672,43,0.90 [0.59-1.38],0.6270621478278712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,24424,47,0.95 [0.74-1.22],0.6794516912433319
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,23920,49,0.99 [0.63-1.56],0.9635953406161945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,20501,41,0.96 [0.29-3.13],0.939690021195757
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,21249,44,1.75 [0.88-3.49],0.1128424330089065
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,21141,44,1.12 [0.65-1.92],0.6806772582470988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,24632,48,1.71 [0.80-3.64],0.1673797949312365
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,23842,46,0.82 [0.60-1.13],0.2225658374821638
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,20920,44,1.30 [0.85-2.00],0.2313424903150277
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",24057,47,1.16 [0.82-1.63],0.4106016310471324
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",24802,48,0.88 [0.62-1.25],0.4759065547188074
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,24722,48,0.97 [0.64-1.47],0.875147253844659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,24057,47,1.14 [0.49-2.61],0.7652295093282132
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,24476,47,3.10 [0.88-10.97],0.0784450782937353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,21249,44,1.31 [0.78-2.21],0.3043911906430442
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,21249,44,0.66 [0.39-1.14],0.1363324217949096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,24057,47,0.88 [0.54-1.42],0.5945464221252856
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,20672,43,1.67 [0.80-3.49],0.1707593305481487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,24515,49,0.86 [0.64-1.16],0.3256484367749392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,21159,43,0.90 [0.63-1.27],0.5501768998214984
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,24057,47,0.84 [0.44-1.62],0.6034687319668552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,20594,43,0.45 [0.18-1.14],0.0913850014416393
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,20778,43,0.96 [0.76-1.21],0.7202218455019862
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,23920,49,0.72 [0.48-1.07],0.1051550998506156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,24739,49,0.90 [0.64-1.25],0.5149018817721874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,21200,44,2.10 [1.31-3.36],0.0020079991693043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,24531,48,2.28 [0.86-6.02],0.0974502935916894
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,20594,43,1.08 [0.52-2.26],0.8309746700748029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,24494,49,0.97 [0.71-1.33],0.8618029974692925
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,21282,44,1.76 [0.66-4.72],0.2623778214199422
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,20640,43,1.09 [0.73-1.63],0.6719773432761118
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,20648,42,0.74 [0.36-1.52],0.4146960972016748
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,20668,42,2.31 [1.16-4.63],0.0178940920855023
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,24560,48,2.05 [1.48-2.84],1.5884403518963197e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,20648,42,1.06 [0.46-2.45],0.8978633003886977
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,24425,49,0.88 [0.48-1.64],0.6973983293213568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,21200,44,0.65 [0.31-1.36],0.2499717963861748
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,24386,47,1.98 [1.15-3.43],0.0143512990750187
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,23928,49,0.90 [0.73-1.12],0.3575474785998384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,24722,48,1.16 [0.42-3.17],0.7720029785968148
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,23874,47,1.24 [0.76-2.01],0.3867566919863646
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,20858,44,1.18 [0.46-2.99],0.7310688321117098
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,21057,43,1.71 [0.76-3.83],0.193526473579886
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,21165,44,1.75 [1.03-2.98],0.0380223398824993
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,21165,44,1.09 [0.96-1.23],0.1844670550645115
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,24348,49,0.98 [0.78-1.23],0.8575879580347422
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,24494,49,0.65 [0.40-1.05],0.0788550327362871
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,23920,49,1.05 [0.62-1.78],0.8611658831386279
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,20501,41,1.47 [0.57-3.78],0.4269391113255478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,21224,44,1.21 [0.71-2.06],0.482679386784354
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,20672,43,1.09 [0.68-1.77],0.7178998432671091
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,24385,49,1.05 [0.68-1.63],0.8248344546345833
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,24321,49,1.06 [0.55-2.05],0.8590189126172014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,24236,49,1.60 [0.83-3.08],0.1561996509367876
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,24494,49,1.09 [0.68-1.75],0.7239036827930656
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,20648,42,1.04 [0.63-1.72],0.8863042293765651
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,24494,49,0.98 [0.80-1.19],0.8097923775752097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,23920,49,0.52 [0.31-0.89],0.0164280663108827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,20007,42,0.88 [0.68-1.15],0.3602652339598445
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",23928,49,0.59 [0.26-1.37],0.2231067521706174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,24292,48,3.59 [2.13-6.07],1.7873501470274603e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,20493,42,0.90 [0.52-1.55],0.7062357230923964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,21257,44,0.99 [0.70-1.41],0.9665275602967928
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,20672,43,1.06 [0.74-1.51],0.7499763585598372
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,24494,49,1.46 [0.94-2.27],0.0922149404354751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,23928,49,1.37 [0.72-2.63],0.3372096569874556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,24072,47,1.42 [0.88-2.29],0.1541076969024165
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,20648,42,0.96 [0.54-1.72],0.8968182919865307
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,24348,49,0.90 [0.65-1.25],0.5356610704285809
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,24561,47,0.77 [0.59-0.99],0.0436017210333229
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,20605,42,1.25 [0.67-2.34],0.4901647392953254
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,21257,44,1.07 [0.43-2.68],0.8843593532494827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,21249,44,5.09 [2.05-12.63],0.0004548341721395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,24797,49,7.88 [3.38-18.37],1.7729530410307547e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,21165,44,1.62 [0.98-2.69],0.061581984233331
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,21165,44,1.51 [0.50-4.55],0.4645205296867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,24448,49,1.69 [0.63-4.57],0.2977782940120608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,24258,49,2.93 [1.42-6.05],0.0036925175248067
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,21200,44,1.93 [1.02-3.67],0.0445408821264513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,24797,49,4.03 [1.49-10.88],0.0059897554383465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,21257,44,3.70 [1.87-7.35],0.0001790464591946
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,20778,43,0.78 [0.48-1.27],0.3151159315136289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,23820,49,1.67 [1.16-2.40],0.005891665981018
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,20858,44,1.45 [0.87-2.44],0.1553980213334889
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,24494,49,3.06 [1.63-5.77],0.0005313997464159
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,24628,48,0.84 [0.68-1.03],0.0947642761560786
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,24739,49,1.41 [0.76-2.62],0.2733482721315217
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,21141,44,1.28 [0.91-1.81],0.153059478967451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,23928,49,1.17 [0.76-1.80],0.4842346886701135
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,20668,42,1.19 [0.62-2.29],0.5923951738558852
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,20594,43,1.06 [0.78-1.45],0.6999520341244079
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,21282,44,1.04 [0.71-1.52],0.8588483341204369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,24397,49,0.95 [0.53-1.68],0.850185114318327
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,24497,48,1.24 [0.48-3.17],0.6592524824182653
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,20840,43,1.30 [0.85-2.00],0.2315974159817397
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,21257,44,0.74 [0.42-1.29],0.2823603542095437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,21257,44,0.87 [0.67-1.14],0.315362041009209
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,21257,44,0.92 [0.66-1.30],0.6486059940896804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,21141,44,0.88 [0.55-1.40],0.5872437739282255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,20594,43,0.71 [0.44-1.12],0.1431991802987856
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,24057,47,0.66 [0.45-0.99],0.043714579544255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,20594,43,0.83 [0.54-1.26],0.3722947592454314
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,20601,42,0.86 [0.49-1.52],0.607471182447501
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,21141,44,1.23 [0.78-1.96],0.3700626313069948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,24494,49,0.80 [0.46-1.39],0.4319525083520515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,23928,49,0.92 [0.53-1.61],0.7765929448273495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,20778,43,0.83 [0.57-1.22],0.351282397330003
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,23920,49,0.57 [0.34-0.98],0.0411570148323147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,24057,47,0.81 [0.52-1.27],0.3649362648542547
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,20672,43,0.41 [0.19-0.89],0.0245479514468249
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,23920,49,0.90 [0.52-1.57],0.7196902493499263
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,20858,44,1.44 [1.08-1.94],0.0145212637546174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,20648,42,1.93 [0.85-4.40],0.1172559534881679
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,21141,44,0.97 [0.54-1.73],0.9148409191302924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,20668,42,0.94 [0.54-1.64],0.8223815191933348
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,20601,42,1.74 [0.86-3.53],0.1258855740120866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,23920,49,1.36 [0.94-1.96],0.1055943056630659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,20648,42,1.04 [0.68-1.59],0.844117065805921
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,20858,44,0.91 [0.52-1.59],0.7424089566865872
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,23920,49,1.06 [0.52-2.17],0.8637810045667664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,24613,48,1.70 [1.15-2.52],0.0076742982631305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,23928,49,0.67 [0.30-1.49],0.3240576110290436
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,20501,41,0.96 [0.47-1.96],0.91865756168441
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,23920,49,1.02 [0.66-1.56],0.9436339371316644
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,21224,44,2.41 [1.70-3.41],8.037535368250389e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,23949,48,1.24 [0.77-1.99],0.374968229624136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,21224,44,0.81 [0.55-1.19],0.281048261924235
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,20594,43,0.99 [0.53-1.84],0.97217704514155
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,20501,41,1.11 [0.59-2.09],0.740369448346978
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,20672,43,1.24 [0.92-1.69],0.1617649363332119
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,24385,49,1.70 [1.27-2.27],0.000321236449427
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,24385,49,1.56 [1.07-2.29],0.0210543865449197
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,21165,44,1.26 [0.85-1.87],0.2432497590691946
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,20648,42,1.17 [0.81-1.69],0.3938130749469263
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,20668,42,0.98 [0.74-1.31],0.8998447420144077
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,21141,44,0.48 [0.20-1.14],0.0968303078128473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,24072,47,1.19 [0.75-1.89],0.4604106159442453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,20668,42,0.55 [0.15-2.08],0.3776172347617694
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,21224,44,0.83 [0.51-1.37],0.4689859516785516
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,24343,48,2.47 [1.76-3.45],1.4415235986804022e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,24797,49,2.26 [1.71-2.98],8.374296080902272e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,24797,49,2.20 [1.65-2.93],8.058122117722272e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,21141,44,1.71 [0.94-3.13],0.0805248027656118
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,24520,47,1.55 [0.93-2.58],0.0945180233417727
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,20648,42,1.11 [0.64-1.92],0.6987501707806055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,24494,48,4.12 [2.07-8.21],5.80631896797021e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REN,Renin,24515,49,1.16 [0.82-1.64],0.4032750179256001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,20648,42,0.85 [0.38-1.91],0.6932499582074348
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,20501,41,0.77 [0.31-1.91],0.5697355649942129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,24385,49,1.02 [0.54-1.94],0.9430801410934556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RETN,Resistin,24422,47,0.81 [0.43-1.51],0.4985062290975134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",20594,43,0.61 [0.27-1.37],0.2336956227116976
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,21141,44,1.61 [0.52-5.00],0.4110811166071819
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,21224,44,0.88 [0.60-1.28],0.4941246171892834
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,20858,44,0.72 [0.41-1.28],0.2632111565466568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,24739,49,2.43 [1.11-5.29],0.0256430708835166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,24739,49,2.21 [0.90-5.44],0.0854694906577317
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,21224,44,0.63 [0.38-1.06],0.0847896949867419
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,24057,47,1.00 [0.68-1.49],0.9840678358937132
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,24197,49,0.80 [0.66-0.98],0.0305025359986907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,20648,42,0.84 [0.42-1.71],0.6372684310701026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,20778,43,1.52 [0.92-2.51],0.1051702662581301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,24659,48,1.03 [0.68-1.57],0.8780910676915984
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,21257,44,0.78 [0.59-1.03],0.0765597546723082
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,20594,43,1.15 [0.79-1.67],0.4587695243899771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,21224,44,0.66 [0.36-1.23],0.1918807977220243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,20746,43,0.80 [0.58-1.10],0.1633755301689117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,21262,44,1.66 [0.54-5.04],0.3754162155028555
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,20668,42,1.53 [0.95-2.45],0.0811744489219857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,24389,48,1.04 [0.84-1.30],0.6998881745826888
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,20576,44,2.85 [1.42-5.72],0.0033344730244219
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,21108,44,1.70 [0.86-3.34],0.127046009970065
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,21224,44,0.83 [0.44-1.57],0.5636231717865376
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,24676,48,3.00 [1.38-6.56],0.0058004397521604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,20668,42,3.68 [1.68-8.06],0.0011028355464777
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,20648,42,1.38 [0.79-2.41],0.2524086592618798
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,20648,42,0.43 [0.15-1.24],0.119172829427824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,20858,44,1.21 [0.82-1.77],0.3345077455618565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,23920,49,0.85 [0.58-1.24],0.3952694908580046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,20858,44,0.88 [0.50-1.55],0.6664842082032622
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,20668,42,0.98 [0.66-1.46],0.9211649960157332
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,24520,47,3.14 [1.17-8.47],0.0237062529427205
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,24739,49,5.28 [2.00-13.97],0.0008035939193551
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,20668,42,7.18 [1.45-35.67],0.0158696944668795
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,24515,49,3.72 [1.73-7.99],0.0007635790055272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,24385,49,0.95 [0.52-1.72],0.8563107668651433
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,20648,42,1.06 [0.42-2.70],0.8994614934884568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,20858,44,0.97 [0.64-1.46],0.8768518880522577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,20672,43,1.13 [0.59-2.17],0.7203848714580499
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,20668,42,0.44 [0.18-1.07],0.0692643190521376
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,20594,43,1.22 [0.67-2.21],0.5226786603841747
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,20672,43,0.86 [0.68-1.08],0.196596525294075
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,23920,49,1.55 [1.15-2.08],0.0042266571655952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,23920,49,0.84 [0.58-1.22],0.3605986637233493
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,20601,42,1.01 [0.73-1.40],0.9509369702668556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,24348,49,0.37 [0.18-0.75],0.0063936480144706
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,24722,48,1.27 [0.51-3.15],0.6083325544566479
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,24385,49,1.63 [0.70-3.78],0.2535998117765078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,20594,43,0.81 [0.42-1.55],0.5264396604417345
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",21224,44,0.88 [0.65-1.21],0.4415468952310022
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,24722,48,1.31 [0.65-2.62],0.4489433347642001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,23920,49,0.86 [0.64-1.14],0.2870295656591237
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,24739,49,0.84 [0.57-1.25],0.395505605196719
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,20594,43,0.88 [0.35-2.26],0.7950930742923125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,24314,48,1.02 [0.60-1.71],0.9527025226548144
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,24153,49,1.34 [0.98-1.84],0.0692575984355222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,20648,42,2.60 [1.45-4.67],0.0014175977243984
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,21224,44,1.30 [0.79-2.13],0.3085700508464536
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,23891,49,1.34 [0.96-1.86],0.0853352305072092
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,21141,44,1.00 [0.53-1.88],0.9964445222843236
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,24550,47,0.69 [0.44-1.07],0.0942059714542503
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,21224,44,1.60 [0.94-2.72],0.0819039470794521
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,24072,47,1.41 [0.99-2.01],0.0603287968463568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,21282,44,1.21 [0.63-2.33],0.562046583842006
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,21224,44,1.60 [0.71-3.58],0.2566818888617401
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,20601,42,1.09 [0.65-1.83],0.7339229716625344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,24494,49,0.80 [0.56-1.14],0.2139009183622588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,20858,44,0.77 [0.48-1.23],0.2751568756061436
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,21190,44,0.86 [0.67-1.11],0.2465534446477029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,20594,43,1.35 [0.78-2.34],0.2774031529537323
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,20594,43,0.74 [0.37-1.49],0.3985335004673989
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,20858,44,0.79 [0.49-1.27],0.3320478831649022
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,21224,44,0.65 [0.21-2.01],0.4568813832977672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,21211,44,1.27 [0.56-2.86],0.5660612186347704
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,24385,49,1.03 [0.77-1.39],0.8193673996966672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,24739,49,3.43 [1.55-7.58],0.0022952663742513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,23928,49,0.63 [0.34-1.19],0.1548990491437236
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,23878,46,4.65 [2.70-8.01],3.194512464709005e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,24797,49,0.79 [0.44-1.44],0.4448368722976993
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,24739,49,2.06 [0.85-4.99],0.1075863082394352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,24624,48,2.82 [1.29-6.13],0.0090445903299369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,24520,47,2.64 [1.23-5.68],0.0127670510954898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,24529,47,2.54 [1.52-4.25],0.0003860109140844
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,20594,43,1.63 [0.89-2.98],0.113602621306344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,20778,43,4.55 [1.53-13.53],0.0064768118952592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,24561,47,0.95 [0.69-1.31],0.7446512617683182
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,24057,47,1.47 [0.85-2.53],0.166688967924501
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,20601,42,1.00 [0.67-1.50],0.9835512969912106
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,24659,48,0.95 [0.58-1.55],0.8354936088034146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,20601,42,0.92 [0.48-1.75],0.7901641083791016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,20672,43,0.47 [0.15-1.51],0.2061970366047266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,20672,43,0.51 [0.19-1.37],0.179678267698352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,20601,42,1.16 [0.64-2.09],0.6224567718768186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,20668,42,0.88 [0.45-1.75],0.7231000841026591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,23920,49,0.77 [0.52-1.14],0.1960659731170079
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,20597,42,0.84 [0.46-1.53],0.5776153994761744
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,21257,44,2.82 [1.52-5.22],0.0009992678096385
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,20668,42,0.91 [0.65-1.29],0.5970874886602529
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,24494,49,1.17 [0.77-1.80],0.4609357803165826
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCT,Secretin,20672,43,1.24 [0.65-2.37],0.5197645919457231
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,24515,49,2.02 [1.32-3.09],0.0012751853283669
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,24515,49,0.22 [0.14-0.34],3.7489753297565576e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,21141,44,0.98 [0.76-1.26],0.8730068274407559
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,21165,44,0.90 [0.58-1.40],0.642635387812305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,20778,43,0.90 [0.40-2.03],0.795457067254876
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,20668,42,0.89 [0.61-1.31],0.5617201824994484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,20668,42,0.87 [0.31-2.42],0.7888936817708638
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,24797,49,0.91 [0.56-1.49],0.7078094339002674
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,21282,44,0.71 [0.20-2.57],0.6040259387507151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,21282,44,0.34 [0.11-1.07],0.0653262474504735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,24560,48,0.80 [0.51-1.24],0.3132765877717574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,24494,49,0.64 [0.31-1.30],0.2154464522893335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,24515,49,6.07 [2.60-14.19],3.1556467663598474e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,20778,43,2.11 [1.24-3.58],0.0059183463042645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,24385,49,1.76 [1.03-3.02],0.0394228859608678
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,24739,49,0.94 [0.41-2.15],0.8870101607195386
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,20648,42,1.02 [0.34-3.07],0.9683088345789204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,24707,49,0.74 [0.28-1.99],0.5552272086713808
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,21224,44,0.75 [0.49-1.14],0.1770105378311941
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,20858,44,0.87 [0.47-1.63],0.6656855151950591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,21152,44,2.15 [1.12-4.12],0.0214346977019039
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,24385,49,0.84 [0.34-2.08],0.7066215508710819
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,20897,44,,
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,24797,49,1.08 [0.63-1.87],0.7772514034982827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,23842,47,0.94 [0.76-1.17],0.5863517281444834
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,21217,44,5.54 [1.68-18.30],0.0050140091614776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,20896,44,0.33 [0.10-1.08],0.0668642071754467
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,20971,44,0.99 [0.41-2.35],0.9755825905488468
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,21282,44,0.79 [0.17-3.64],0.7610233694707947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,21282,44,1.69 [0.39-7.40],0.4831994014784521
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,24263,49,1.33 [0.96-1.84],0.0850990713906772
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,24418,48,0.82 [0.61-1.09],0.1746275784001301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,24072,47,0.75 [0.47-1.19],0.2230342676598351
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,24662,49,0.79 [0.52-1.21],0.2813962605935257
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,24802,48,1.14 [0.77-1.67],0.5150438461559528
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,24348,49,0.68 [0.33-1.41],0.2953496844165028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,21240,44,0.98 [0.14-6.86],0.9808656786601072
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,21240,44,1.72 [0.64-4.60],0.2813970658930321
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,24797,49,0.78 [0.55-1.10],0.1594012255966191
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,21257,44,0.69 [0.44-1.09],0.1158387326306514
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,20975,44,2.06 [0.78-5.40],0.1434002277578963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,20890,44,5.19 [0.79-34.11],0.0863908286322988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,21240,44,,
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,20858,44,1.03 [0.82-1.29],0.7909612635011135
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,20732,43,0.50 [0.18-1.39],0.1851931627736486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,21165,44,1.28 [0.81-2.02],0.2936837823993795
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,23928,49,0.75 [0.49-1.13],0.1696423319712819
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,24271,49,1.12 [0.50-2.49],0.7888328041693049
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,20672,43,1.31 [0.55-3.11],0.5347725933351536
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,24550,47,2.41 [0.99-5.85],0.0529241502524332
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,24385,49,2.66 [1.12-6.29],0.025897595128032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,24385,49,0.98 [0.70-1.37],0.8875849139705885
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,24264,49,1.07 [0.60-1.90],0.8249300350249458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,20778,43,0.75 [0.38-1.48],0.4055289824518594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,23920,49,0.74 [0.44-1.26],0.2726025734284564
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,23920,49,1.84 [1.24-2.72],0.0024500010565462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,24515,49,1.74 [1.20-2.54],0.0036489946225123
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,20920,44,0.78 [0.46-1.35],0.3827540931616827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,23920,49,0.78 [0.61-1.00],0.0537396342172337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,24494,49,0.84 [0.52-1.36],0.4788660954807159
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,20601,42,1.00 [0.62-1.62],0.99880750990396
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,21165,44,0.68 [0.34-1.35],0.2691287245770045
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,20730,44,1.24 [0.89-1.74],0.2066603044075655
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,21200,44,1.04 [0.69-1.59],0.838326231618661
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,21262,44,0.56 [0.34-0.91],0.0190499078071595
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,20501,41,0.76 [0.56-1.03],0.0735590284190917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,20559,43,1.04 [0.75-1.44],0.8192766545223376
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,20648,42,1.07 [0.54-2.09],0.8504077978185204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,21249,44,3.80 [2.13-6.78],6.207795395956034e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",24561,47,1.04 [0.77-1.39],0.8129662329072951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,20858,44,0.37 [0.14-1.00],0.0499152866521662
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,24507,47,0.84 [0.49-1.44],0.5284922754297141
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,24596,47,3.35 [2.15-5.25],1.111162030906721e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,24494,49,4.11 [2.42-6.96],1.565728474609135e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,23928,49,0.88 [0.61-1.27],0.4902867432353882
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,24494,48,1.12 [0.88-1.43],0.3586106713411405
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,24722,48,0.45 [0.22-0.91],0.0263829927366448
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,24515,49,2.55 [1.16-5.59],0.0192967176582752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,20668,42,1.80 [0.98-3.33],0.0595485350601489
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,24691,48,1.15 [0.50-2.60],0.7458093812820641
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,20668,42,0.76 [0.27-2.16],0.6059599848986771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,24544,49,1.19 [0.75-1.88],0.4630244963679505
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,24425,47,2.52 [1.47-4.33],0.0008246626601241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,20648,42,0.93 [0.64-1.35],0.6918928726273185
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,24385,49,0.83 [0.63-1.11],0.2088641930137763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",23928,49,0.92 [0.56-1.50],0.731657210341679
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,24057,47,0.89 [0.56-1.42],0.6387788600018296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,24301,49,0.52 [0.36-0.75],0.0004752801968213
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,24596,47,0.87 [0.68-1.11],0.2693664506064036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,20594,43,1.27 [0.69-2.33],0.4382252972038505
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,21224,44,0.78 [0.60-1.02],0.071874012091767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,24057,47,1.00 [0.64-1.55],0.9989500656113944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,23920,49,1.75 [0.98-3.13],0.0571610169552089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,24494,49,0.50 [0.32-0.79],0.0026146841192576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,23920,49,3.60 [2.42-5.36],2.8566185805020593e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,20594,43,1.31 [0.54-3.18],0.5550073291841582
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,21141,44,0.84 [0.47-1.50],0.5545610733562791
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,23928,49,0.73 [0.44-1.21],0.2175321455721637
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,20672,43,0.63 [0.32-1.27],0.1965627742253022
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,23928,49,0.87 [0.57-1.32],0.5037199574660067
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,20501,41,1.23 [0.82-1.85],0.3088102119210741
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,20501,41,0.79 [0.39-1.62],0.5238768895875763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,23928,49,1.60 [0.87-2.96],0.1328204515676389
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,24494,49,1.30 [0.93-1.84],0.1278205259112248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,20672,43,1.12 [0.77-1.62],0.5471478824013852
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,21249,44,1.09 [0.61-1.95],0.7798652193179858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,20594,43,1.21 [0.86-1.69],0.2773299485362773
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,20778,43,0.81 [0.57-1.14],0.2303869598539161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,21165,44,1.16 [0.73-1.85],0.5320391852367281
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",20501,41,0.76 [0.41-1.42],0.3953739393734086
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,23928,49,0.82 [0.49-1.39],0.4617565708981157
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,20648,42,0.81 [0.33-2.01],0.6554521901918854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,24722,48,1.65 [0.87-3.12],0.1247538838998486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,24072,47,2.22 [1.29-3.84],0.004240256431441
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,20858,44,0.78 [0.48-1.27],0.3135744673914673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,21165,44,1.07 [0.76-1.49],0.715630896019491
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,21099,44,1.45 [0.84-2.50],0.1783993850619679
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,23920,49,0.78 [0.57-1.07],0.1254697076287966
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,21141,44,0.80 [0.52-1.23],0.3083733622888785
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,21141,44,0.91 [0.51-1.61],0.740325141441331
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,24385,49,1.34 [0.39-4.57],0.6416809575995017
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,23928,49,0.56 [0.37-0.84],0.0045931039146469
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,20501,41,1.24 [0.78-1.96],0.3572263240782337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,21165,44,0.95 [0.60-1.52],0.8369866770000114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,24722,48,3.36 [1.76-6.44],0.0002550545690253
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,24596,47,1.75 [0.97-3.16],0.0625977986503116
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,24620,49,0.91 [0.55-1.50],0.7002592678601114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,20648,42,1.21 [0.82-1.78],0.347268086664341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,24545,47,0.98 [0.66-1.44],0.9144727618114152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,21141,44,0.75 [0.45-1.25],0.26322141512884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,20601,42,0.77 [0.45-1.33],0.354840392275497
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,21153,44,0.94 [0.69-1.28],0.7008183048415908
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,24515,49,0.81 [0.62-1.06],0.1310648394378701
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,20601,42,0.75 [0.40-1.42],0.3796319312127543
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,24550,47,0.92 [0.70-1.21],0.5439510468323833
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,21224,44,0.71 [0.42-1.19],0.1931835162479368
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,20778,43,0.94 [0.73-1.21],0.6325960358611974
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,24348,49,1.45 [0.97-2.16],0.0676096166481407
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",20668,42,1.19 [0.49-2.89],0.6998365557385693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',21200,44,1.18 [0.73-1.92],0.5062880400485796
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,20594,43,0.90 [0.55-1.47],0.6733541497192723
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,20778,43,1.13 [0.67-1.91],0.642763078931341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,21165,44,0.51 [0.23-1.14],0.1026453568828212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,21141,44,1.42 [1.08-1.87],0.0123631528381544
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,20668,42,0.45 [0.15-1.38],0.1622127306241693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,24515,49,1.03 [0.71-1.48],0.8860873904774256
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],23964,47,1.02 [0.61-1.71],0.9455355043911484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",24494,48,1.39 [0.76-2.55],0.2859724874465571
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,21262,44,0.70 [0.36-1.38],0.304903320501258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,21224,44,1.71 [1.15-2.53],0.0073744346408296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,23920,49,4.07 [2.25-7.37],3.5850405174527784e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,24613,48,1.19 [0.83-1.70],0.3458206398487103
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,24487,49,0.62 [0.31-1.23],0.170577611494499
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,24487,49,1.45 [0.78-2.72],0.2410918754062563
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,20672,43,1.24 [0.76-2.03],0.393568184663175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,21188,44,0.83 [0.24-2.90],0.7698648057710811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,20672,43,2.38 [0.87-6.49],0.09061295479963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,21224,44,1.46 [0.69-3.08],0.325866317047381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,21224,44,1.14 [0.73-1.79],0.5599760699950075
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,24550,47,0.77 [0.55-1.08],0.1267700908804452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,24479,48,2.12 [1.12-4.02],0.021358681525437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPART,Spartin,20778,43,0.91 [0.62-1.32],0.6084833580632218
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,21257,44,0.97 [0.39-2.38],0.9391060652108464
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,24494,48,2.13 [1.32-3.46],0.0020460997998786
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,20778,43,0.39 [0.19-0.81],0.0114594912074298
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,24494,49,1.15 [0.78-1.70],0.4686862531498635
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,24494,48,1.72 [0.84-3.54],0.1395851490941421
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,24722,48,1.49 [0.95-2.35],0.0841862050019625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,20594,43,1.03 [0.48-2.19],0.9481903856902882
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,24407,48,2.22 [1.08-4.57],0.0294207364870381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,24596,47,0.93 [0.50-1.72],0.8065021171339462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,21165,44,0.96 [0.87-1.06],0.4304606104571918
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,24348,49,0.78 [0.29-2.07],0.6184649601733219
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,24520,47,2.34 [1.21-4.50],0.0110006958828689
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,24400,48,2.77 [1.42-5.41],0.0028462511199958
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,24750,49,3.11 [1.91-5.05],4.921476896113528e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",20648,42,1.05 [0.55-2.00],0.8911637498102102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,20501,41,1.31 [0.90-1.91],0.1548554784962085
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,20858,44,0.93 [0.64-1.34],0.6932903219172959
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,21200,44,1.12 [0.75-1.68],0.5706377586521572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,24057,47,0.96 [0.73-1.28],0.797942302676924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",20601,42,1.41 [0.64-3.11],0.3902994678755233
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,21200,44,0.80 [0.34-1.92],0.6244717451053887
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,24510,47,0.87 [0.71-1.07],0.1869648426533501
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,24385,49,0.82 [0.55-1.23],0.338726322888887
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,24494,49,0.86 [0.62-1.19],0.3621075119039055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,21257,44,1.35 [0.58-3.15],0.4810625966731299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,23928,49,0.72 [0.42-1.24],0.2337289505732178
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",20648,42,0.56 [0.21-1.52],0.2564410307184988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,24487,49,1.21 [0.99-1.47],0.0573658608286208
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,24560,48,1.65 [0.92-2.95],0.0897919941499114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,20501,41,0.86 [0.30-2.42],0.7680064234647062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,21165,44,0.75 [0.41-1.36],0.344782846892019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,20778,43,0.86 [0.51-1.46],0.5835888743236988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",24385,49,1.20 [0.71-2.03],0.5037396520512294
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",24797,49,1.52 [0.66-3.50],0.3282133439125245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",20648,42,0.94 [0.49-1.79],0.8393667582526253
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,21249,44,2.48 [1.02-6.04],0.045353227983473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,21141,44,0.81 [0.36-1.83],0.612385966191826
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,24301,49,0.79 [0.53-1.17],0.2439729498791115
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,20648,42,0.96 [0.65-1.41],0.8335336384925195
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,24385,49,0.86 [0.72-1.03],0.1040710848967313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,20501,41,1.27 [0.89-1.82],0.187109466613486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,24739,49,2.17 [1.34-3.50],0.0015284202558806
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,24456,48,3.53 [1.32-9.44],0.0118111581231646
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,20601,42,0.63 [0.36-1.11],0.1088222831362599
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,24451,48,0.91 [0.61-1.35],0.6323013684560226
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,24072,47,0.85 [0.59-1.21],0.3650124132211786
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,23928,49,0.80 [0.53-1.22],0.2961691383065307
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,24515,49,0.80 [0.60-1.06],0.1239393392631461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",20501,41,1.10 [0.83-1.47],0.4985115789734351
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,23920,49,1.28 [0.89-1.85],0.1787214639154013
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,20672,43,0.87 [0.40-1.88],0.7258879861053326
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,21200,44,1.32 [0.72-2.42],0.3765291492391948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,24385,49,1.13 [0.78-1.63],0.5333288954702518
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,20648,42,0.73 [0.31-1.72],0.4700220556881946
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,23920,49,0.96 [0.66-1.41],0.8461089914998968
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,20648,42,1.18 [0.66-2.11],0.571669848788719
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,24494,49,1.01 [0.61-1.67],0.9559990205638714
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,21224,44,0.96 [0.67-1.39],0.8342324436469337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,23920,49,0.87 [0.47-1.61],0.6529006312862287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,21165,44,0.49 [0.21-1.10],0.084726353764903
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,23920,49,0.88 [0.64-1.20],0.4185384491469606
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,24739,49,0.89 [0.74-1.08],0.2417785415379313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,24494,49,1.41 [1.01-1.98],0.043636251387896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,20648,42,0.99 [0.65-1.53],0.9775860568659084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,24739,49,0.83 [0.53-1.29],0.4004512811073817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",21224,44,1.04 [0.67-1.62],0.8464538914389569
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,24072,47,0.92 [0.54-1.56],0.7479843645222884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,24494,48,1.64 [0.77-3.48],0.1975347538420658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,21141,44,1.56 [0.92-2.65],0.1015290849455702
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,20668,43,2.83 [1.27-6.34],0.0113419209756053
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,20672,43,0.89 [0.54-1.47],0.6453599196073131
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,21165,44,1.72 [1.10-2.69],0.016967012913267
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,20778,43,0.92 [0.54-1.56],0.7553301111267785
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,20601,42,0.74 [0.40-1.39],0.3468504824129776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,21200,44,0.96 [0.44-2.10],0.9131129895544012
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,21257,44,0.84 [0.55-1.27],0.4030762128121647
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,20858,44,0.89 [0.68-1.16],0.3844001548416617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,24385,49,0.94 [0.76-1.16],0.5706233120562083
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,21739,45,1.55 [0.63-3.80],0.3397271741762306
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,21141,44,0.50 [0.23-1.07],0.0724768863932383
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,24385,49,3.01 [1.64-5.51],0.0003535671556753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,20501,41,0.94 [0.56-1.56],0.8010243615799724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,21179,44,0.88 [0.47-1.64],0.6939905065919408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,24057,47,0.87 [0.60-1.27],0.4792155734293941
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,20858,44,0.83 [0.46-1.48],0.5191159773224245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,23928,49,0.88 [0.64-1.22],0.4353048626714451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",20672,43,1.09 [0.77-1.55],0.6160101829896139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",21141,44,1.01 [0.47-2.18],0.9806115687906948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,21200,44,1.03 [0.66-1.63],0.8878099369706746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,23928,49,0.99 [0.56-1.74],0.9598255356235686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,24385,49,0.88 [0.66-1.16],0.3567662377415733
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,24494,49,0.89 [0.64-1.24],0.4905724818825745
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,20778,43,0.90 [0.64-1.26],0.5438149683034752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,24348,49,0.89 [0.70-1.13],0.3235341239040521
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,24348,49,0.75 [0.55-1.03],0.0740386142667704
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,23920,49,0.89 [0.66-1.19],0.4257567460131153
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,20672,43,0.80 [0.39-1.65],0.5493319791275574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,24302,48,1.23 [0.95-1.59],0.122847273674041
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,24072,47,1.06 [0.79-1.42],0.7052339915147973
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,20840,44,0.83 [0.35-1.99],0.680354212847497
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,24750,49,2.15 [1.11-4.17],0.0232555750849195
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,21257,44,1.94 [1.05-3.56],0.0331181948473508
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,20858,44,1.14 [0.76-1.72],0.5168992658888419
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,21257,44,1.66 [0.65-4.22],0.28901809088388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,23928,49,1.06 [0.89-1.27],0.4887479550523861
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",20672,43,0.93 [0.43-2.02],0.854337836177142
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,21141,44,1.20 [0.86-1.67],0.2788276956085462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,23928,49,0.91 [0.67-1.24],0.5541118553018785
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,20594,43,0.55 [0.26-1.20],0.1361557372794129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,24550,47,5.47 [1.92-15.64],0.0015047259437402
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,20648,42,0.82 [0.29-2.37],0.7209207543220717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,20829,44,0.84 [0.59-1.22],0.3618165571298126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,20672,43,0.58 [0.36-0.93],0.0247034845436455
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,20858,44,1.00 [0.48-2.09],0.9939710949976605
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,21282,44,0.20 [0.06-0.72],0.0133578915412611
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,20601,42,1.03 [0.63-1.68],0.8952478002505073
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,24383,48,1.20 [0.88-1.62],0.2471738692021488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,24561,47,1.47 [1.01-2.16],0.046190485926639
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,24461,47,1.34 [0.91-1.96],0.1353901044353888
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,24400,48,2.03 [1.18-3.49],0.0105754477338926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,24467,47,1.05 [0.57-1.94],0.8653974899252204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,24579,48,1.33 [0.72-2.45],0.3585283402257683
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,21141,44,1.17 [0.92-1.49],0.1997701219303889
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,24494,49,1.34 [0.82-2.21],0.2424293962839676
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,24754,48,1.07 [0.56-2.04],0.8391302391703471
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,21141,44,1.00 [0.58-1.70],0.9874856277195694
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,24323,48,1.60 [0.64-3.97],0.3161522886890536
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,20648,42,0.98 [0.26-3.62],0.9713328207451464
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,24550,47,4.36 [2.59-7.36],3.1428652332476834e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,24797,49,2.45 [1.09-5.54],0.0309111179540157
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,24471,48,1.25 [0.89-1.74],0.1966522706356978
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,21262,44,4.84 [1.86-12.55],0.0011988566000446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,20458,41,0.94 [0.65-1.34],0.7185480602129724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,24515,49,6.71 [3.39-13.29],4.7793975090649896e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,24494,48,1.59 [0.85-2.96],0.142901013447349
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,24489,48,1.64 [0.95-2.83],0.0765341432767895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,24416,49,1.58 [0.77-3.22],0.2105972323743272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,24072,47,3.97 [2.16-7.30],8.591129179378377e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,20594,43,0.66 [0.43-1.01],0.0538917407805781
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,20498,42,1.35 [0.63-2.91],0.4457602494947713
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,21100,44,0.83 [0.60-1.15],0.2565365158822399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,24739,49,5.40 [2.65-11.01],3.4053879085793627e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,23806,46,0.86 [0.69-1.07],0.1818161954420837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,24797,49,1.23 [0.64-2.38],0.5302061203544399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",23881,49,1.10 [0.66-1.85],0.7088990630811673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,20858,44,1.88 [1.29-2.75],0.0011345718143354
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,24560,48,2.86 [1.74-4.70],3.478851564524061e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,21257,44,0.95 [0.46-1.95],0.8831033270238842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,21200,44,0.80 [0.57-1.12],0.2003374016849565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,24199,47,1.97 [0.90-4.33],0.0915355214504519
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,21257,44,0.90 [0.26-3.15],0.8735183826886503
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,24596,47,0.97 [0.80-1.18],0.7493640936325557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,24494,48,0.88 [0.47-1.66],0.7004729020684732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,24441,49,4.23 [1.62-11.04],0.0031653317212488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,24550,47,0.82 [0.60-1.12],0.2048656177599508
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,20601,42,0.87 [0.41-1.84],0.7225237387435266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",20858,44,1.55 [1.02-2.35],0.0389595991190542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,20648,42,1.26 [0.41-3.82],0.6885141866007698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,20858,44,1.77 [0.52-5.95],0.3583712919490438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,24802,48,1.49 [0.94-2.34],0.086496059955638
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,20648,42,2.14 [0.88-5.18],0.0914744717512506
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,20672,43,0.85 [0.47-1.53],0.5822535813604941
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,20858,44,0.54 [0.28-1.02],0.0594047287625971
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,20594,43,0.85 [0.42-1.72],0.6569821314135216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,20594,43,0.68 [0.35-1.34],0.2704923271798553
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,21165,44,0.87 [0.66-1.14],0.3004754202799286
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,21141,44,0.79 [0.52-1.20],0.2616337585977873
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,20668,42,0.69 [0.43-1.12],0.1308622227745829
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,21224,44,1.33 [0.79-2.25],0.2881153014019845
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,20501,41,1.04 [0.51-2.15],0.9085211561292532
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,20601,42,0.93 [0.62-1.41],0.7483907084857351
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,21152,44,1.44 [0.71-2.91],0.3118574962786085
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,24385,49,1.03 [0.78-1.37],0.8161575054218786
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,24223,48,2.08 [1.04-4.16],0.0396504503995557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,24494,48,0.98 [0.71-1.36],0.919633887883216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,24560,48,1.63 [0.97-2.72],0.0640395920652335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,24031,47,1.80 [1.34-2.42],9.208610794136824e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,21165,44,1.01 [0.57-1.79],0.9713770029071948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,24057,47,0.64 [0.31-1.33],0.2334541992437601
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,20778,43,0.71 [0.43-1.15],0.1617185440430745
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,24348,49,2.42 [1.45-4.04],0.0007632883889291
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,24348,49,1.42 [1.08-1.86],0.0117813797811088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,24531,49,0.88 [0.53-1.44],0.6031600349257111
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,24802,48,2.58 [1.43-4.66],0.0017116005576624
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,24476,47,1.20 [0.52-2.78],0.6644995316535516
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,24550,47,2.46 [1.32-4.58],0.0044793795033499
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,24520,47,,
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,24057,47,0.61 [0.32-1.14],0.1233523183299861
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,24520,47,2.32 [1.06-5.07],0.0345185237395169
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,20778,43,0.22 [0.12-0.41],1.5846329450141884e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,24722,48,3.62 [1.98-6.61],2.8520685923269265e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,24494,48,5.04 [2.73-9.33],2.4559751434999625e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,24494,48,1.99 [1.48-2.66],4.193060280578002e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,24739,49,5.65 [2.64-12.09],8.148164430311546e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,24754,48,5.51 [3.48-8.71],2.786996378462698e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,24348,49,1.82 [1.30-2.54],0.0004396000277282
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,24739,49,2.94 [2.02-4.27],1.5415707975103985e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,24348,49,3.16 [2.08-4.81],7.1196814541368e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,24802,48,2.76 [1.07-7.11],0.0356340284722623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,24494,49,1.30 [0.87-1.95],0.2045238350758729
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,24802,48,0.58 [0.24-1.38],0.2177519573055253
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,24596,47,4.77 [2.04-11.14],0.0003097638931065
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,24747,49,,
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,24348,49,0.76 [0.49-1.18],0.2251833562953853
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,21249,44,1.98 [0.96-4.07],0.0633007068319698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,21200,44,0.87 [0.63-1.22],0.4234331199113744
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,21249,44,0.63 [0.32-1.22],0.168505788397709
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",24072,47,1.48 [1.09-2.01],0.0122935790546964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,20858,44,0.80 [0.35-1.85],0.6011065988863724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,24348,49,0.58 [0.33-1.04],0.065786677898123
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,24494,48,0.92 [0.35-2.45],0.8717912071219276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,21257,44,1.04 [0.72-1.50],0.8390409518662327
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,21165,44,0.85 [0.66-1.08],0.180356472353261
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",20501,41,0.53 [0.25-1.15],0.108658860268221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,20648,42,0.88 [0.60-1.30],0.5282709302495542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,20668,42,0.80 [0.44-1.48],0.4822020283668877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,23920,49,1.31 [0.76-2.27],0.3342382430270575
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,20648,42,1.03 [0.73-1.44],0.8743480901886457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,20324,43,1.14 [0.67-1.96],0.631519056929452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,24072,47,1.75 [1.07-2.87],0.0267962312701878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,20672,43,1.14 [0.49-2.67],0.7547912327291023
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,20672,43,0.79 [0.36-1.75],0.5590677215773687
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,20778,43,0.81 [0.63-1.05],0.1074610854199191
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,21257,44,2.56 [0.99-6.62],0.052156961234553
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,20594,43,1.77 [1.19-2.62],0.0045881915241083
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,23920,49,0.79 [0.55-1.14],0.2090534579917653
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,24325,47,1.02 [0.59-1.74],0.9461084072721268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,20858,44,1.03 [0.72-1.47],0.8769054735535053
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,23928,49,0.94 [0.48-1.81],0.8472940998180636
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,20594,43,1.34 [0.90-1.99],0.1453362137192627
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,20501,41,0.86 [0.50-1.47],0.5699704777714731
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,24762,48,1.07 [0.66-1.73],0.7873815009301697
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,21224,44,1.34 [0.73-2.46],0.3437924348153158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,20648,42,1.53 [0.62-3.80],0.3573927255676955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,24057,47,0.74 [0.45-1.23],0.250877067251933
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,24494,49,1.14 [0.81-1.61],0.4501829261550268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",20648,42,0.88 [0.39-2.00],0.7591245392714302
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,20594,43,0.58 [0.26-1.31],0.1913372448433812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,20858,44,0.71 [0.48-1.06],0.0920144065597133
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,21249,44,0.94 [0.64-1.37],0.7392407061986026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,24476,47,1.43 [0.90-2.26],0.1282070336139591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,21262,44,0.66 [0.37-1.15],0.1433816429011002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,24494,48,1.27 [0.60-2.68],0.532605605267765
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,24722,48,0.99 [0.67-1.47],0.963412819343064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,24494,49,0.95 [0.68-1.31],0.7435438097077156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,20812,44,0.94 [0.60-1.47],0.7712108466897764
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,21165,44,0.96 [0.74-1.25],0.7565775166686879
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,20501,41,0.64 [0.33-1.22],0.1731202427710019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,20672,43,0.66 [0.43-1.00],0.0515239629323699
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,24494,49,0.96 [0.72-1.29],0.7893238627706884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,21141,44,1.09 [0.78-1.52],0.6108727533121667
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,20594,43,0.99 [0.55-1.79],0.9780992854023348
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,20648,42,1.06 [0.74-1.54],0.7446238942612495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,21224,44,0.88 [0.57-1.37],0.5784719186913222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,24515,49,1.01 [0.73-1.41],0.9401698667257196
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,24072,47,0.89 [0.56-1.43],0.6351865594699682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,20594,43,0.79 [0.37-1.68],0.5438337350063452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,24072,47,1.18 [0.67-2.09],0.5721489054892028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,20594,43,0.64 [0.30-1.36],0.2477872166235359
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,20601,42,0.78 [0.52-1.17],0.2264957231291356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,21165,44,1.06 [0.80-1.40],0.6802041703490104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,20648,42,0.37 [0.16-0.86],0.0214175104892956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,23897,49,0.94 [0.67-1.31],0.7084131001075844
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,20672,43,0.81 [0.44-1.51],0.5115313599052247
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TTN,Titin,20594,43,1.37 [1.01-1.85],0.0417837530387777
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,21049,43,0.48 [0.17-1.34],0.1615224909052114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,20601,42,1.60 [0.64-3.99],0.3155887656143938
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,21249,44,0.75 [0.53-1.07],0.1114930507124851
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,20858,44,1.09 [0.76-1.55],0.6459481943966705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,24348,49,0.89 [0.67-1.18],0.4062824207440936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,20907,44,0.92 [0.47-1.81],0.8026597813176484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,24550,47,2.49 [1.10-5.62],0.0281369361601449
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,24739,49,0.91 [0.63-1.32],0.6165526396243344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,21200,44,0.64 [0.35-1.18],0.151602392590222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,20564,42,1.12 [0.85-1.46],0.4203844780849807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",24494,48,0.73 [0.42-1.28],0.2749228476161239
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,24365,49,1.03 [0.71-1.49],0.8874435176509863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,24515,49,3.21 [1.33-7.74],0.0094166986057863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",20648,42,2.69 [1.61-4.49],0.0001622568096544
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,24385,49,1.65 [0.82-3.33],0.1613843303530082
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,21141,44,1.21 [0.47-3.11],0.694742182685551
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,21257,44,1.21 [0.78-1.90],0.3944709133621837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,20648,42,0.94 [0.56-1.59],0.8224588435776512
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,20594,43,0.82 [0.39-1.71],0.5899520318932183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,20778,43,0.78 [0.50-1.20],0.2559520971565922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,21165,44,0.84 [0.69-1.03],0.0886958375814352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,20594,43,1.15 [0.91-1.45],0.2455725777744947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,20594,43,1.03 [0.45-2.37],0.9395505163899937
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,24348,49,2.64 [1.51-4.63],0.0007069767768798
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,24711,49,0.65 [0.43-0.99],0.0437402740497159
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,20648,42,2.23 [1.05-4.74],0.0374087755908046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,20501,41,0.96 [0.56-1.64],0.880490692435948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,21141,44,0.90 [0.38-2.13],0.8195198904908796
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,21257,44,0.93 [0.68-1.26],0.6316810244223259
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,20601,42,0.88 [0.47-1.64],0.680500059686632
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,20822,44,0.64 [0.30-1.36],0.2423752356829053
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,20778,43,0.79 [0.52-1.20],0.2638827336480934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,20672,43,0.76 [0.47-1.24],0.2716468251896056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,24385,49,0.89 [0.68-1.18],0.423993785254247
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,21141,44,1.01 [0.68-1.50],0.953599865378599
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,21200,44,1.32 [0.72-2.42],0.3612097129037694
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,20594,43,0.95 [0.67-1.35],0.7916081718691079
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,24072,47,0.83 [0.63-1.10],0.1870779469621003
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,23920,49,0.92 [0.56-1.50],0.7313255390597058
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,24072,47,1.36 [0.93-1.97],0.1101750879501516
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,20648,42,0.82 [0.58-1.16],0.2606572272405428
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,24494,49,0.72 [0.52-0.99],0.0455867276512487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,24091,47,4.82 [2.52-9.20],1.859102775013197e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,21262,44,0.72 [0.47-1.08],0.1088914020285069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,24385,49,2.09 [0.63-6.94],0.2282450491542447
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,20601,42,0.97 [0.72-1.31],0.8493683657042592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,24531,48,7.39 [3.80-14.37],3.657718316508425e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,24739,49,2.93 [1.37-6.27],0.0056840845561661
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,20501,41,0.60 [0.36-1.01],0.0561019954810717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,24723,48,1.25 [0.82-1.89],0.2961497419240019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,20648,42,0.29 [0.11-0.79],0.0154062638650912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,24550,47,0.77 [0.49-1.22],0.2642320072534059
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,24762,48,0.85 [0.43-1.70],0.6472354681754265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,21224,44,1.76 [0.72-4.30],0.2136546394080395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,24072,47,0.96 [0.78-1.18],0.7067503075062298
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,20668,42,1.39 [0.53-3.69],0.5045115069898709
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,21257,44,1.79 [0.92-3.47],0.084729921303347
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,24385,49,1.77 [1.17-2.69],0.0072171543926763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,21262,44,1.52 [0.99-2.32],0.0559703855849602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,24385,49,0.92 [0.55-1.54],0.7464346441669489
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,20858,44,0.70 [0.44-1.13],0.1491927518125415
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,24385,49,0.94 [0.68-1.29],0.6875344991494232
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,21141,44,0.81 [0.59-1.10],0.1696643822892188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,24385,49,0.82 [0.58-1.15],0.2502123415332358
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,21141,44,0.93 [0.42-2.04],0.8470816784796041
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,20594,43,0.54 [0.20-1.41],0.206465235270242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,21141,44,1.65 [1.07-2.54],0.0228890685662935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,24456,48,3.56 [2.24-5.65],6.920320901390364e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,24479,48,0.67 [0.42-1.06],0.0881000160035825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,21200,44,1.14 [0.60-2.19],0.6835236194964921
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,23928,49,1.01 [0.60-1.70],0.9766098649170644
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,20858,44,1.03 [0.52-2.04],0.9252752063403602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,24072,47,1.21 [0.82-1.79],0.3265850444506445
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,24739,49,0.74 [0.52-1.06],0.1002033932543535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,23920,49,0.99 [0.45-2.17],0.9818890956866576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,20778,43,0.93 [0.56-1.55],0.7908754324716638
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,24690,48,1.70 [0.97-2.97],0.0614115223243462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,20501,41,0.96 [0.64-1.42],0.8233355400647078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,24260,49,1.45 [0.78-2.71],0.2372471368152158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,21224,44,0.96 [0.51-1.80],0.902407761219344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,24797,49,1.16 [0.83-1.63],0.3861605117871917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",24494,48,1.65 [0.85-3.22],0.1421538232310311
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,24057,47,1.08 [0.74-1.57],0.6858668612842018
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,24072,47,0.92 [0.69-1.22],0.553411059179453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,23928,49,1.01 [0.75-1.36],0.9546602640979014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,21200,44,0.88 [0.59-1.30],0.5138676003344598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,20648,42,0.53 [0.28-1.00],0.0494328419201137
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,21141,44,0.62 [0.26-1.51],0.2933364171356892
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,20725,43,1.32 [0.87-2.01],0.1885098697017514
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,24679,47,1.28 [0.89-1.83],0.1765516738518251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,23214,46,3.69 [2.39-5.70],3.899531581355415e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",24271,49,0.84 [0.47-1.52],0.5672723902337209
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",24520,47,1.05 [0.49-2.25],0.904252339606122
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,24722,48,2.27 [1.12-4.62],0.0232103002271796
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,24057,47,2.00 [0.97-4.13],0.0611101422139949
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,24348,49,0.81 [0.50-1.31],0.3869463458144698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,24722,48,1.64 [1.23-2.18],0.0007027507670941
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,24669,49,2.17 [1.16-4.03],0.0146275632435917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,20648,42,0.77 [0.45-1.32],0.3428075558165682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,24550,47,0.79 [0.63-1.00],0.0549564150631325
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,23928,49,0.79 [0.38-1.62],0.5157483138453265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,21200,44,4.26 [2.20-8.28],1.8446612102096703e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",21165,44,0.98 [0.81-1.19],0.8317590599395739
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,24385,49,1.00 [0.80-1.25],0.989511122706067
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,21141,44,0.69 [0.27-1.74],0.4329601787543671
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,20594,43,1.34 [0.86-2.09],0.1892679883614333
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,24057,47,0.89 [0.66-1.21],0.4627894373415574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,20778,43,0.81 [0.54-1.22],0.3193491316986446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,20648,42,0.90 [0.30-2.65],0.8469570242102737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,20648,42,1.50 [0.90-2.49],0.1161030741285587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,23920,49,1.01 [0.71-1.44],0.9576105459653385
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,24072,47,1.44 [0.90-2.32],0.1317815562100913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,20594,43,0.88 [0.52-1.49],0.6253169097276365
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,21165,44,0.74 [0.54-1.01],0.0595563122452181
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,21200,44,1.27 [0.66-2.46],0.4728507170946459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,20648,42,0.48 [0.16-1.45],0.191656476822377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,20858,44,1.05 [0.67-1.65],0.8353242189357961
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,21141,44,0.46 [0.26-0.83],0.0091512569412183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,21165,44,1.31 [0.89-1.93],0.1770702483575338
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,21141,44,0.59 [0.33-1.06],0.0789261889862359
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,20668,42,1.07 [0.95-1.21],0.2782877819505234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,20501,41,0.69 [0.23-2.11],0.520507340418344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,20601,42,1.05 [0.79-1.42],0.7248911782056104
